Publications published since 2010 from OUS - Department of Haematology

988 publications found

Publications 2025

1. Ailawadhi S, Špička I, Spencer A, Lu J, Oriol A, Ling S, Schjesvold F, Berkovits A, Hus M, Li C, Dimopoulos MA, Rajnics P, Beşışık SK, Hungria V, Custidiano MDR, Parmar G, Leleu X, Li F, Cerchione C, Gomez C, Ishida T, Mateos MV, Buck TT, LeBlanc R, Minařík J et al. (2025)
   Isatuximab Subcutaneous by On-Body Injector Versus Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase III IRAKLIA Study
   J Clin Oncol, 43 (22), 2527-2537
   DOI 10.1200/JCO-25-00744, PubMed 40459178
2. Ailawadhi S, Špička I, Spencer A, Lu J, Oriol A, Ling S, Schjesvold F, Berkovits A, Hus M, Li C, Dimopoulos MA, Rajnics P, Beşışık SK, Hungria V, Custidiano MDR, Parmar G, Leleu X, Li F, Cerchione C, Gomez C, Ishida T, Mateos MV, Buck TT, LeBlanc R, Minařík J et al. (2025)
   Erratum: Isatuximab Subcutaneous by On-Body Injector Versus Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase III IRAKLIA Study
   J Clin Oncol, 43 (27), 3056
   DOI 10.1200/JCO-25-01767, PubMed 40779730
3. Andersen K, Tjønnfjord GE, Hestdalen ML, Spetalen S, Panagopoulos I (2025)
   Complex Genetic Evolution and Treatment Challenges in Myeloid Neoplasms: A Case of Persistent t(2;3)(p15~23;q26)/MECOM Rearrangement, SF3B1 Mutation, and Transient TNIP1::PDGFRB Chimera
   Cancer Genomics Proteomics, 22 (1), 24-33
   DOI 10.21873/cgp.20483, PubMed 39730178
4. Andresen MS, Mowinckel MC, Skarpen E, Andersen E, Sandset PM, Chollet ME, Stavik B (2025)
   Identification and evaluation of Pharmacological enhancers of the factor VII p.Q160R variant
   Sci Rep, 15 (1), 14315
   DOI 10.1038/s41598-025-98689-3, PubMed 40274887
5. Askeland FB, Haukås E, Slørdahl TS, Klostergaard A, Alexandersen T, Lysén A, Abdollahi P, Nielsen LK, Hermansen E, Schjesvold F (2025)
   Isatuximab, bortezomib, lenalidomide, and limited dexamethasone in patients with transplant-ineligible multiple myeloma (REST): a multicentre, single-arm, phase 2 trial
   Lancet Haematol, 12 (2), e120-e127
   DOI 10.1016/S2352-3026(24)00347-8, PubMed 39909655
6. Astermark J, Ranta S, Myrin-Westesson L, Hoffmann M, Quere S, Sanchez AYC, Robson S, Czirok T, Lassila R, Holme PA (2025)
   Health-Related Quality of Life, Physical Activity and Joint Health in People With Severe Haemophilia A Receiving Emicizumab: Results From the Phase IV HemiNorth 2 Study
   Haemophilia (in press)
   DOI 10.1111/hae.70121, PubMed 40898745
7. Atar D, Vandenbriele C, Agewall S, Gigante B, Goette A, Gorog DA, Holme PA, Krychtiuk KA, Rocca B, Siller-Matula JM, Valgimigli M, Rubboli A, Klamroth R (2025)
   Management of patients with congenital bleeding disorders and cardiac indications for antithrombotic therapy
   Eur Heart J Cardiovasc Pharmacother, 11 (3), 275-289
   DOI 10.1093/ehjcvp/pvaf006, PubMed 40145128
8. Bazarbachi A, Galimard JE, Dalle IA, Socié G, Versluis J, Wu D, Eder M, Labussière-Wallet H, Yakoub-Agha I, Maertens J, Forcade E, Gedde-Dahl T, Choi G, Castilla-Llorente C, Baron F, Brissot E, Esteve J, Nagler A, Mohty M, Ciceri F (2025)
   Challenging the Adverse Label: Diverse Outcomes of ELN 2022 Adverse Cytogenetic Subgroups in Acute Myeloid Leukemia Patients Allografted in First Remission: From EBMT ALWP
   Am J Hematol, 100 (8), 1374-1386
   DOI 10.1002/ajh.27726, PubMed 40445901
9. Bergland BS, Remberger M, Tjønnfjord GE, Vo CD, Myhre AE, Abrahamsen IW, Gedde-Dahl T, Tvedt THA (2025)
   Should a young matched unrelated donor be preferred over an older matched related donor in allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome?
   Bone Marrow Transplant, 60 (7), 1062-1064
   DOI 10.1038/s41409-025-02579-1, PubMed 40251418
10. Bertamini L, Fokkema C, Rodriguez-Otero P, van Duin M, Terpos E, D'Agostino M, van der Velden VHJ, van de Donk NWCJ, Delforge M, Driessen C, Hajek R, Einsele H, Vangsted AJ, Vieyra D, Attar RM, Sitthi-Amorn A, Carson R, Schjesvold F, Robak P, Beksac M, Spencer A, Broijl A, Cupedo T, Moreau P, Boccadoro M et al. (2025)
    Circulating tumor cells predict myeloma outcomes in patients treated with daratumumab, bortezomib, lenalidomide, and dexamethasone
    Blood (in press)
    DOI 10.1182/blood.2025030113, PubMed 41060326
11. Bolli N, D'Agostino M, Bagratuni T, Boccadoro M, Cavo M, Driessen C, Einsele H, Engelhardt M, Gay F, Gutiérrez NC, Hájek R, Holien T, João C, Kaiser M, Kortüm KM, Leypoldt L, Moreau P, Musto P, Ocio EM, Raab MS, Rasche L, Schjesvold F, Sevcikova T, Terpos E, Touzeau C et al. (2025)
    European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma
    Hemasphere, 9 (10), e70216
    DOI 10.1002/hem3.70216, PubMed 41089883
12. Brunetti M, Andersen K, Spetalen S, Tjønnfjord GE, Heim S, Micci F (2025)
    Cryptic Rearrangement of the KMT2A Gene in a B-cell Acute Lymphoblastic Leukemia
    Anticancer Res, 45 (3), 921-928
    DOI 10.21873/anticanres.17479, PubMed 40037847
13. Busterud K, Remberger M, Bentsen PT, Jerm MB, Gedde-Dahl T, Olsnes AM, Tjønnfjord GE (2025)
    Allogeneic stem cell transplantation for acute myeloid leukaemia 2005-22
    Tidsskr Nor Laegeforen, 145 (12)
    DOI 10.4045/tidsskr.25.0001, PubMed 41097944
14. Costa LJ, Banerjee R, Mian H, Weisel K, Bal S, Derman BA, Htut MM, Nagarajan C, Rodriguez C, Richter J, Frigault MJ, Ye JC, van de Donk NWCJ, Voorhees PM, Puliafito B, Bahlis N, Popat R, Chng WJ, Ho PJ, Kaur G, Kapoor P, Du J, Schjesvold F, Berdeja J, Einsele H et al. (2025)
    International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myeloma
    Leukemia, 39 (3), 543-554
    DOI 10.1038/s41375-024-02482-6, PubMed 39870767
15. Desai N, Al-Shaibani E, Alfaro-Moya T, Law AD, Lam W, Remberger M, Pasic I, Novitzky-Basso I, Viswabandya A, Kim DD, Kumar R, Lipton JH, Mattsson J, Michelis FV (2025)
    Impact of graft-versus-host disease prophylaxis on second primary malignancies after allogeneic haematopoietic stem cell transplantation
    Br J Haematol, 207 (3), 938-945
    DOI 10.1111/bjh.70006, PubMed 40682490
16. Dimopoulos MA, Terpos E, Boccadoro M, Moreau P, Mateos MV, Zweegman S, Cook G, Engelhardt M, Delforge M, Hajek R, Schjesvold F, Gay F, Manier S, Weisel KC, Kaiser M, van de Donk NWCJ, Zamagni E, Rodriguez-Otero P, Perrot A, Driessen C, Bila J, Laane E, Dytfeld D, Touzeau C, Beksac M et al. (2025)
    EHA-EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma
    Nat Rev Clin Oncol, 22 (9), 680-700
    DOI 10.1038/s41571-025-01041-x, PubMed 40624367
17. Dybedal I, Iversen N, Jacobsen AF, Bjørge L, Chaireti R, Henriksson CE, Schultz NH, Hvas AM, Sandset PM, Weedon-Fekjær H, Bremme K, Abildgaard U (2025)
    Hereditary antithrombin deficiency and venous thrombosis in pregnancy-results of a retrospective multicenter study
    J Thromb Haemost, 23 (9), 2807-2818
    DOI 10.1016/j.jtha.2025.03.001, PubMed 40086756
18. Ernst MPT, Versluis J, Valk PJM, Bierings M, Tamminga RYJ, Hooimeijer LH, Döhner K, Gresele P, Tawana K, Langemeijer SMC, Van der Reijden BA, Podgornik H, Sever M, Tvedt THA, Vulliamy T, Fitzgibbon J, Dokal I, Baliakas P, Bastida JM, Pohlkamp C, Haferlach T, Larcher L, Soulier J, Schutgens REG, Freson K et al. (2025)
    Disease characteristics and outcomes of acute myeloid leukemia in germline RUNX1 deficiency (Familial Platelet Disorder with associated Myeloid Malignancy)
    Hemasphere, 9 (1), e70057
    DOI 10.1002/hem3.70057, PubMed 39822584
19. Esteve J, Nagler A, Labopin M, Versluis J, Sanz J, Gedde-Dahl T, Burns D, Roeven M, Labussière-Wallet H, von dem Borne P, van Gorkom G, Contentin N, Neubauer A, Wagner-Drouet EM, Kröger N, Mohty M, Ciceri F (2025)
    Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Genetic Features: Relevance of the Genetic Underlying Category. A Retrospective Analysis on Behalf of the Acute Leukemia Working Party of the EBMT
    Am J Hematol, 100 (6), 954-962
    DOI 10.1002/ajh.27647, PubMed 40062532
20. Frøen HM, Brodtkorb M, Holte H, Kolstad A, Myhre AE, Remberger M, Tjønnfjord GE, Gedde-Dahl T (2025)
    Allogeneic stem cell transplantation for patients with lymphoma 2011-21
    Tidsskr Nor Laegeforen, 145 (3)
    DOI 10.4045/tidsskr.24.0443, PubMed 40042014
21. Gudmundstuen AM, Iversen PO, Pesonen M, Hjermstad MJ, Bye A, Tjønnfjord GE, Skaarud KJ (2025)
    Comparing indirect calorimetry and predictive equations for energy expenditure - 1 year follow-up of adult hematopoietic stem cell transplanted recipients
    Clin Nutr ESPEN, 70, 218-226 (in press)
    DOI 10.1016/j.clnesp.2025.09.027, PubMed 41038512
22. Gundesen MT, Schjesvold F, Lund T (2025)
    Treatment of myeloma bone disease: When, how often, and for how long?
    J Bone Oncol, 52, 100680
    DOI 10.1016/j.jbo.2025.100680, PubMed 40242221
23. Gurnari C, Robin M, Adès L, Aljurf M, Almeida A, Duarte FB, Bernard E, Cutler C, Della Porta MG, De Witte T, DeZern A, Drozd-Sokolowska J, Duncavage E, Fenaux P, Gagelmann N, Garcia-Manero G, Haferlach C, Haferlach T, Hasserjian R, Hellström-Lindberg E, Jacoby M, Kulasekararaj A, Lindsley RC, Maciejewski JP, Makishima H et al. (2025)
    Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT
    Blood, 145 (18), 1987-2001
    DOI 10.1182/blood.2024025131, PubMed 39970324
24. Güven M, Peczynski C, Boreland W, Blaise D, Peffault de Latour R, Yakoub-Agha I, Gedde-Dahl T, Salmenniemi U, Forcade E, Passweg J, Chevallier P, Sandrine L, Mielke S, Broers A, Ceballos P, Byrne J, Castilla-Llorente C, Maertens J, Huynh A, Cerretti R, Bulabois CE, van Gorkom G, Crawley C, Graham C, Mussetti A et al. (2025)
    The impact of ABO compatibility on allogeneic hematopoietic cell transplantation outcomes: a contemporary and comprehensive study from the transplant complications working party of the EBMT
    Bone Marrow Transplant, 60 (7), 956-963
    DOI 10.1038/s41409-025-02580-8, PubMed 40246943
25. Halstensen TD, Hardeland C, Ghanima W, Grøndahl VA, Hubin A, Jørgensen CT, de Wit K, Tavoly M (2025)
    External validation of the DAYS score for suspected deep vein thrombosis
    Res Pract Thromb Haemost, 9 (4), 102885
    DOI 10.1016/j.rpth.2025.102885, PubMed 40599363
26. Haukeland-Parker S, Jervan Ø, Ghanima W, Spruit MA, Holst R, Gleditsch J, Tavoly M, Stavem K, Steine K, Atar D, Dahm AEA, Klok FA, Johannessen HH (2025)
    Exercise capacity, dyspnea, and quality of life 6 months after exercise-based rehabilitation in patients with persistent dyspnea following pulmonary embolism
    Res Pract Thromb Haemost, 9 (2), 102736
    DOI 10.1016/j.rpth.2025.102736, PubMed 40242191
27. Henoun Loukili N, Gras L, Koster L, Blaise D, Gedde-Dahl T, Maertens J, Friis LS, Mielke S, Chevallier P, Passweg JR, Byrne JL, Salmenniemi U, Ceballos P, Cornillon J, Sica S, Onida F, Scheid C, Gurnari C, Drozd-Sokolowska J, Raj K, Robin M, McLornan DP, Yakoub-Agha I (2025)
    Conditioning intensity in myelodysplastic patients aged ≥ 50 years undergoing allogeneic hematopoietic cell transplantation (allo-HCT): a study on behalf of the chronic malignancies working party of the EBMT
    Bone Marrow Transplant (in press)
    DOI 10.1038/s41409-025-02682-3, PubMed 40883614
28. Hermansen JU, Athanasiadis P, Yin Y, Rise AF, Arribas AJ, Cascione L, Russnes HG, Helland Å, Mato AR, Bertoni F, Tjønnfjord GE, Aittokallio T, Skånland SS (2025)
    Proteasome inhibition overcomes resistance to targeted therapies in B-cell malignancy models and in an index patient
    Cell Death Dis, 16 (1), 555
    DOI 10.1038/s41419-025-07884-7, PubMed 40701968
29. Hjertholm KG, Iversen PO, Holmboe-Ottesen G, Jepsen R (2025)
    Risk factors for undernutrition and poor growth during the first 6 months of life in sub-Saharan Africa: A scoping review
    Clin Nutr ESPEN, 68, 309-318
    DOI 10.1016/j.clnesp.2025.05.019, PubMed 40383255
30. Holme PA, Poulsen LH, Tueckmantel C, Maas Enriquez M, Alvarez Román MT, De Cristofaro R (2025)
    Safety and Efficacy of Damoctocog Alfa Pegol Prophylaxis in Patients With Severe Haemophilia A: Results of an Interventional, Post-Marketing Study
    Haemophilia (in press)
    DOI 10.1111/hae.70099, PubMed 40838268
31. Holstein SA, Atrash S, Mian H, Dimopoulos MA, Schjesvold F, Popat R, Shah N, Gatt ME, Gocke CB, Frenzel L, Touzeau C, Beksac M, Manier S, Magen H, Travis P, Nadeem O, Suryanarayan K, Li C, Li S, Nelson A, Cherepanov D, Parot X, Vogl DT (2025)
    A phase 2 randomized study of modakafusp alfa as a single agent for patients with relapsed/refractory multiple myeloma
    Blood, 146 (9), 1051-1064
    DOI 10.1182/blood.2024027873, PubMed 40279508
32. Iacobelli S, Schönland S, Koster L, Blaise D, Nicholson E, Broers AEC, Chevallier P, Reményi P, Folber F, Gribben JG, Nur E, Rabin N, Collin M, Gedde-Dahl T, Bailey K, Ferguson P, Stelljes M, Bloor A, Beksac M, Drozd-Sokolowska J, Raj K, Hayden PJ, Yakoub-Agha I, McLornan DP, Kröger N (2025)
    Outcomes following different upfront stem cell transplantation strategies for multiple myeloma: a statistical perspective on behalf of the Chronic Malignancies Working Party of the EBMT
    Bone Marrow Transplant, 60 (10), 1361-1368
    DOI 10.1038/s41409-025-02675-2, PubMed 40739129
33. Iversen PO, Gedde-Dahl T, Tjønnfjord GE, Ali MM (2025)
    Quality of life the first year after allogeneic haematopoietic stem cell transplantation-A randomized controlled trial examining extracorporeal photophoresis to prevent graft-versus-host disease
    Br J Haematol (in press)
    DOI 10.1111/bjh.70119, PubMed 40875520
34. Klevmoen M, Mulder JWCM, Bogsrud MP, Retterstøl K, Vesterbekkmo EK, Pedersen EKR, Freiberger T, Vrablik M, Vaclova M, Hovland A, Vethe NT, Brekke HK, Iversen PO, Veierød M, Roeters van Lennep J, Holven KB (2025)
    Prospective study on breastfeeding, lipid profile and cardiovascular risk markers in women with familial hypercholesterolaemia: study protocol for the FH-FEMINA study
    BMJ Open, 15 (4), e092208
    DOI 10.1136/bmjopen-2024-092208, PubMed 40288796
35. Kopland M, Ottersen VS, Dahle DO, Gedde-Dahl T, Dalgaard J (2025)
    En mann i 50-årene med akutt nyresvikt, anemi og trombocytopeni
    Tidsskr Nor Laegeforen, 145 (1)
    DOI 10.4045/tidsskr.24.0231, PubMed 39835860
36. Mishra V, Gedde-Dahl T, Remberger M, Solvang G, Selvaag KL, Fosseng A, Abrahamsen IW, Myhre AE, Hagen TP, Tjønnfjord GE (2025)
    Hospital at Home Following Allogeneic Hematopoietic Stem Cell Transplantation: An Economic Analysis
    Healthcare (Basel), 13 (14)
    DOI 10.3390/healthcare13141648, PubMed 40724674
37. Moore KLF, Rognvaldsson S, Szabo AG, Vaitekėnaitė V, Loigom D, Genell A, Thorsen J, Norgaard JN, Thorsteinsdottir S, Knut-Bojanowska D, Lysen A, Schjesvold F, Peceliunas V, Kaare A, Palk K, Parnat M, Sigurdsson A, Vangsted AJ, Blimark CH (2025)
    Use of upfront autologous stem cell transplantation in myeloma patients aged >65 years: a population-based study by the Nordic Myeloma Study Group
    Haematologica (in press)
    DOI 10.3324/haematol.2025.287344, PubMed 40905090
38. Nagler A, Ferhat AT, Kayser S, Eder M, Kröger N, Stelljes M, Maertens J, Peffault de Latour R, Blau IW, Schroeder T, Reményi P, Gedde-Dahl T, Bug G, Blaise D, Bazarbachi A, Esteve J, Mohty M, Ciceri F (2025)
    Prognostic significance of cytogenetic risk score in patients with secondary acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-matched unrelated donors: a study from the ALWP /EBMT
    Bone Marrow Transplant, 60 (9), 1218-1227
    DOI 10.1038/s41409-025-02620-3, PubMed 40442255
39. Pedersen TH, Tjønnfjord E, Korkama ES, Vikman M, Ahmadi A, Overgaard UM, Kjellander C (2025)
    The incidence of paroxysmal nocturnal hemoglobinuria cell clones in the Nordic countries
    Ann Hematol, 104 (8), 4277-4283
    DOI 10.1007/s00277-025-06450-7, PubMed 40632273
40. Podgorica M, Drivet E, Vestbøstad J, Kvam AK, Wik HS, Munthe L, Schjerven H (2025)
    Azaindole 1, a selective Rock1/2 kinase inhibitor, induces G2/M arrest and cell death in B-cell acute lymphoblastic leukemia (B-ALL)
    Leuk Lymphoma, 1-5 (in press)
    DOI 10.1080/10428194.2025.2536125, PubMed 40728071
41. Posadas-Cantera S, Mitsuiki N, Emmerich F, Patiño V, Lorenz HM, Neth O, Dybedal I, Taskén K, Schäffer AA, Grimbacher B, Gámez-Díaz L (2025)
    The effect of HLA genotype on disease onset and severity in CTLA-4 insufficiency
    Front Immunol, 15, 1447995
    DOI 10.3389/fimmu.2024.1447995, PubMed 39835139
42. Prata PH, Eikema DJ, Piepenbroek B, Kulasekararaj A, Drexler B, Tjon JM, Vaht K, Aljurf M, Chevallier P, Gedde-Dahl T, Kaare A, Salmenniemi U, Schroeder T, Byrne J, Cornillon J, Barraco F, Maertens J, Tholouli E, Platzbecker U, Kröger N, Blaise D, Sica S, Zeiser R, Risitano AM, De Latour RP (2025)
    Hematopoietic stem cell transplantation is effective in achieving long-term survival for post-aplastic anemia myeloid neoplasms: the EBMT Severe Aplastic Anemia Report
    Haematologica (in press)
    DOI 10.3324/haematol.2024.287205, PubMed 40605711
43. Quist-Paulsen P, Horvei L, Dalgaard J, Moksnes M, Eilertsen AL, Paulson M, Azrakhsh NA, Majeed W, Wik HS (2025)
    Improved outcomes in elderly patients with acute lymphoblastic leukaemia using a paediatric-based protocol-A prospective study
    Br J Haematol (in press)
    DOI 10.1111/bjh.70159, PubMed 40947499
44. Rasmussen B, Nilsson L, Tobiasson M, Jädersten M, Garelius H, Dybedal I, Grønbaek K, Ejerblad E, Lorenz F, Flogegård M, Marcher CW, Cavalier L, Ebeling F, Olsnes AM, Nørgaard JM, Saft L, Möllgård L, Hellström-Lindberg E, Schlegelberger B, Göhring G (2025)
    Influence of Cytogenetics on the Outcome of Patients With High-Risk Myelodysplastic Syndrome Including Deletion 5q Treated With Azacitidine With or Without Lenalidomide
    Genes Chromosomes Cancer, 64 (2), e70029
    DOI 10.1002/gcc.70029, PubMed 39921387
45. Richardson P, Beksaç M, Oriol A, Lindsay J, Schjesvold F, Galli M, Yağcı M, Larocca A, Weisel K, Yu X, Donahue C, Acosta J, Peluso T, Dimopoulos M (2025)
    Pomalidomide, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Final Survival and Subgroup Analyses From the OPTIMISMM Trial
    Eur J Haematol, 114 (5), 822-831
    DOI 10.1111/ejh.14365, PubMed 39777934
46. Richardson PG, Perrot A, San-Miguel J, Beksac M, Spicka I, Leleu X, Schjesvold F, Moreau P, Dimopoulos MA, Huang SY, Minarik J, Cavo M, Prince HM, Anderson KC (2025)
    A plain language summary of the ICARIA study, comparing isatuximab-pomalidomide- dexamethasone with pomalidomide- dexamethasone in people with multiple myeloma
    Future Oncol, 21 (6), 653-663
    DOI 10.1080/14796694.2025.2449781, PubMed 39851267
47. Richter J, Nooka A, Rodríguez-Otero P, Schjesvold F, Katodritou E, Combe E, Scott M, Cooper L, Sly I, Ballew N, Bitetti J, Boytsov N, Purser M, McNamara S (2025)
    Belantamab Mafodotin Plus Proteasome Inhibition Efficacy Versus Comparators in Early Relapsed Myeloma: A Systematic Review and Network Meta-Analysis
    Am J Hematol, 100 (6), 998-1009
    DOI 10.1002/ajh.27661, PubMed 40143674
48. Rodriguez-Otero P, Voorhees PM, Boccadoro M, Laubach J, Einsele H, Sborov DW, Dimopoulos MA, Broijl A, Mina R, Spencer A, Schjesvold F, Silbermann R, Gay F, Costa LJ, Perrot A, Liu Y, Wang J, Sitthi-Amorn A, Carson R, Cortoos A, Usmani SZ, Richardson PG, Moreau P, Sonneveld P, Kaufman JL (2025)
    Daratumumab for newly diagnosed multiple myeloma: Pooled analysis of patients aged ≥65 years from GRIFFIN and PERSEUS
    Clin Lymphoma Myeloma Leuk, 25 (10), 746-758.e6
    DOI 10.1016/j.clml.2025.04.007, PubMed 40360369
49. Roman G, Lauritzen KH, Harrison SP, Bhattacharya A, Andresen MS, Mowinckel MC, Smolkova B, Henriksson CE, Glosli H, Iversen N, Thiede B, Sullivan GJ, Almaas R, Sandset PM, Stavik B, Chollet ME (2025)
    Ex vivo correction of severe coagulation Factor VII deficiency in patient-derived 3D liver organoids
    Haematologica (in press)
    DOI 10.3324/haematol.2025.288046, PubMed 41063698
50. Ru Y, Chen J, Ferhat AT, Labussière-Wallet H, Gedde-Dahl T, Kröger N, Socié G, Yakoub-Agha I, Eder M, Mielke S, Wu D, Mohty M, Ciceri F, Gorin NC (2025)
    Similar Outcome With Haploidentical, Matched Sibling, or Matched Unrelated Donor Hematopoietic Cell Transplantation for Adult Patients With Adverse-Risk TP53-Mutated Acute Myeloid Leukemia in First Remission: A Comparative Study From the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Am J Hematol (in press)
    DOI 10.1002/ajh.70069, PubMed 40927841
51. Rüfer A, Nilius H, Hermine O, Niedoszytko M, Oude Elberink JNG, Bonadonna P, Shoumariyeh K, Gulen T, Hartmann K, Sabato V, Angelova-Fischer I, Baffoe D, Christen D, Belloni Fortina A, Breynaert C, Brockow K, von Bubnoff N, Bumbea H, van Daele P, Doubek M, Dybedal I, Elena C, Fokoloros C, Górska A, Heizmann M et al. (2025)
    Prognostic impact of expression of CD2, CD25, and/or CD30 in/on mast cells in systemic mastocytosis: a registry study of the European Competence Network on Mastocytosis
    Leukemia, 39 (3), 675-683
    DOI 10.1038/s41375-024-02504-3, PubMed 39815050
52. Raab MS, Cohen YC, Schjesvold F, Aardalen K, Oka A, Spencer A, Wermke M, Souza AD, Kaufman JL, Cafro AM, Ocio EM, Doki N, Henson K, Trabucco G, Carrion A, Bender FC, Juif PE, Fessehatsion A, Fan L, Stonehouse JP, Blankenship JW, Granda B, De Vita S, Lu H (2025)
    Correction: Preclinical discovery and initial clinical data of WVT078, a BCMA × CD3 bispecific antibody
    Leukemia, 39 (6), 1545
    DOI 10.1038/s41375-025-02516-7, PubMed 40374810
53. Selvaag KL, Eriksen S, Nickelsen M, Solvang G, Vemøy K, Tjønnfjord GE, Lærum-Onsager E (2025)
    Allogeneic Haematopoietic Stem Cell Transplantation Recipients' Experiences of Outdoor Physical Activity: A Qualitative Study
    Scand J Caring Sci, 39 (1), e70016
    DOI 10.1111/scs.70016, PubMed 40075514
54. Singh PB, Singh SV, Iversen PO, Jensen JL (2025)
    Evaluation and management of chemosensory, trigeminal, and salivary dysfunctions in patients with post Coronavirus Disease
    Clin Nutr ESPEN (in press)
    DOI 10.1016/j.clnesp.2025.10.018, PubMed 41115655
55. Skøyeneie SCT, Wik HS, Tjønnfjord GE, Fauske L, Gedde-Dahl T, Myhre AEL (2025)
    Family Caregivers’ Experiences of Hospital at Home FollowingAllogeneic Haematopoietic Stem Cell Transplantation: AQualitative Study
    European Journal of Cancer Care, 2025 (1), 7043910
    DOI 10.1155/ecc/7043910, PublikaID 544
56. Skaarud KJ, Gudmundstuen AM, Pesonen M, Hjermstad MJ, Iversen PO, Tjønnfjord GE (2025)
    The role of fat-soluble vitamins for graft-versus host disease after myeloablative conditioning in allogeneic stem cell transplanted patients
    Sci Rep, 15 (1), 1675
    DOI 10.1038/s41598-024-84805-2, PubMed 39799129
57. Slørdahl TS, Askeland FB, Hanssen MSS, Hov H, Sundt-Hansen SM, Lindahl S, Vethe NT, Hjorth-Hansen H, Fenstad MH, Waage A, Hjertner Ø, Schjesvold F, Sundan A (2025)
    Combined Proteasome and Autophagy Inhibition in Relapsed/Refractory Multiple Myeloma-A Phase I Trial of Hydroxychloroquine, Carfilzomib, and Dexamethasone
    EJHaem, 6 (1), e1091
    DOI 10.1002/jha2.1091, PubMed 39866949
58. Smit AJT, Van der Maas NG, Van der Holt B, Van Norden Y, Van Werkhoven E, Vangsted AJ, Ypma PF, Visser-Wisselaar HA, Troia R, Boccadoro M, Löwenberg B, Janssen JJWM, Ossenkoppele GJ, Schjesvold F, Sonneveld P, Zweegman S, Versluis J, Cornelissen JJ (2025)
    The added value of Bayesian interim analysis in randomized phase II and phase III clinical trials in hemato-oncology
    Haematologica (in press)
    DOI 10.3324/haematol.2025.288675, PubMed 41035401
59. Spencer A, Gavriatopoulou M, Coriu D, Lysén A, Gutierrez NC, Escalante F, Fantl D, Hajek R, Seguro F, Kaur G, Bittencourt RI, Bašić-Kinda S, Chu MP, Safah H, Martínez-López J, Crusoé EQ, De Farias DLC, Offidani M, Askari E, Sevindik OG, Maisnar V, Teng CJ, Hughes O, Taylor R, Lehn K et al. (2025)
    Prospective real-world evaluation of t(11;14) prevalence and disease biology in multiple myeloma: MEDICI study analysis
    Blood Adv (in press)
    DOI 10.1182/bloodadvances.2025017214, PubMed 40829119
60. Svalastoga M, Larsen TL, Brekke J, Enden T, Frøen H, Garresori H, Jacobsen EM, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA (2025)
    Effect of drug interactions with apixaban on clinical outcomes in cancer patients with venous thromboembolism
    Front Oncol, 15, 1520725
    DOI 10.3389/fonc.2025.1520725, PubMed 39931081
61. Teimori K, Larsen BS, Austli MB, Nilsson N, Tho I, Nezvalova-Henriksen K (2025)
    Strategies for Assessing Physical Compatibility of Calcium Folinate with Bicarbonate During Methotrexate Rescue Therapy in Pediatric Patients with Acute Lymphoblastic Leukemia
    Pharmaceutics, 17 (9)
    DOI 10.3390/pharmaceutics17091155, PubMed 41012494
62. Thorsteinsdóttir S, Lemonakis K, Slørdahl TS, Rögnvaldsson S, Richardson AK, Hermansen E, Thorsen J, Schjesvold F, Moore KLF, Szabo AG, Andersen MK, Waage A, Blimark CH, Vangsted A, Nordic Myeloma Study Group (2025)
    Cytogenetic abnormalities in multiple myeloma patients according to age: A real-world study by the Nordic Myeloma Study Group
    Br J Haematol, 207 (4), 1638-1642
    DOI 10.1111/bjh.70030, PubMed 41070698
63. Tjønnfjord EB, Tveten K, Spetalen S, Tjønnfjord GE (2025)
    ANKRD26 Gene Mutation and Thrombocytopenia-Is the Risk of Malignancy Dependent on the Mutation Variant?
    Hematol Rep, 17 (4)
    DOI 10.3390/hematolrep17040037, PubMed 40863182
64. Tvedt THA, Qvigstad C, Nezvalova-Henriksen K, Bergland BS, Bruserud Ø, Reikvam H (2025)
    Three-Month Posttransplant Lipidomic Profile Reflects Acute GVHD but Not Chronic GVHD Risk in Allogeneic Stem Cell Recipients
    Eur J Haematol (in press)
    DOI 10.1111/ejh.70011, PubMed 40840957
65. van de Donk NWCJ, Moreau P, San-Miguel JF, Mateos MV, Dimopoulos MA, Zweegman S, Gay F, Engelhardt M, Mina R, Zamagni E, Delforge M, Beksac M, Spencer A, Schjesvold F, Driessen C, Kaiser M, Perrot A, Wäsch R, Korst CL, Broijl A, Touzeau C, Manier S, Hajek R, Ludwig H, Fernandez de Larrea C et al. (2025)
    Optimising T-cell immunotherapy in patients with multiple myeloma: practical considerations from the European Myeloma Network
    Lancet Haematol, 12 (8), e635-e649
    DOI 10.1016/S2352-3026(25)00117-6, PubMed 40580975
66. Vonk CM, Grob T, Rijken M, Kavelaars FG, Konijnenburg JML, Ossenkoppele GJ, Manz MG, Havelange V, Fløisand Y, Löwenberg B, Valk PJM (2025)
    Advantages of a genomic DNA-based next-generation sequencing assay for detection of mutant NPM1 measurable residual disease in AML
    Blood Adv, 9 (5), 1069-1077
    DOI 10.1182/bloodadvances.2024014490, PubMed 39637308
67. Våtsveen TK, Giliberto M, Bjornsdottir V, Centonze F, Besse A, Frey Y, Skånland SS, Tveita A, Alirezaylavasani A, Imbery JF, Misund K, Reiterer V, Zahoor M, Driessen C, Besse L, Tasken K, Schjesvold FH, Farhan H, Munthe LA (2025)
    Targeting proteostasis in multiple myeloma through inhibition of LTK
    Leukemia, 39 (9), 2237-2245
    DOI 10.1038/s41375-025-02682-8, PubMed 40634511
68. Yang T, Rasmussen ASB, Weimann A, Thastrup M, Rank CU, Als-Nielsen B, Malmros J, Wik HS, Lohi O, Overgaard U, Johannsdottir IMR, Vaitkeviciene G, Dalhoff K, Schmiegelow K, Lund TM (2025)
    Published Population Pharmacokinetic Models of Imatinib Perform Poorly on TDM Data from Pediatric Patients
    Target Oncol, 20 (5), 871-886
    DOI 10.1007/s11523-025-01172-2, PubMed 40920292
69. Ye Y, Labopin M, Yakoub-Agha I, Socié G, Blaise D, Gedde-Dahl T, Blau IW, Raiola AM, Byrne J, Daguindau E, Labussière-Wallet H, Huynh A, Bazarbachi A, Nagler A, Brissot E, Li L, Luo Y, Shi J, Mohty M, Huang H, Ciceri F (2025)
    Superior GVHD-Free, Relapse-Free Survival for Haploidentical Transplant With PTCy Than Matched Unrelated Donor for AML Patients Transplanted in Second Complete Remission: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Am J Hematol, 100 (10), 1760-1771
    DOI 10.1002/ajh.70008, PubMed 40650544

Publications 2024

1. Abdollahi P, Norseth HM, Schjesvold F (2024)
   Advances and challenges in anti-cancer vaccines for multiple myeloma
   Front Immunol, 15, 1411352
   DOI 10.3389/fimmu.2024.1411352, PubMed 39161773
2. Al Hamed R, Labopin M, Wu D, Gedde-Dahl T, Aljurf M, Forcade E, Salmenniemi U, Passweg J, Maertens J, Pabst T, Versluis J, Itäla-Remes M, Huang XJ, Van Gorkom G, Schroeder T, Sanz J, Blaise D, Reményi P, Schanz U, Esteve J, Gorin NC, Ciceri F, Mohty M (2024)
   Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT
   Bone Marrow Transplant, 59 (10), 1458-1465
   DOI 10.1038/s41409-024-02373-5, PubMed 39095548
3. Andersen K, Tjønnfjord GE, Ramslien LF, Panagopoulos I (2024)
   RUNX1::MIR99AHG Chimera in Acute Myeloid Leukemia
   Genes Chromosomes Cancer, 63 (9), e23272
   DOI 10.1002/gcc.23272, PubMed 39324493
4. Arrieta-Bolaños E, Bonneville EF, Crivello P, Robin M, Gedde-Dahl T, Salmenniemi U, Kröger N, Yakoub-Agha I, Crawley C, Choi G, Broers AEC, Forcade E, Carre M, Poiré X, Huynh A, Lenhoff S, Ciceri F, Tholouli E, Schroeder T, Deconinck E, Carlson K, de Wreede LC, Hoogenboom JD, Malard F, Ruggeri A et al. (2024)
   Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic Malignancies
   J Clin Oncol, 42 (28), 3287-3299
   DOI 10.1200/JCO.24.00582, PubMed 39167735
5. Arrieta-Bolaños E, van der Burg LLJ, Gedde-Dahl T, Robin M, Salmenniemi U, Kröger N, Yakoub-Agha I, Huynh A, Crawley C, Deconinck E, Bulabois CE, Forcade E, Tholouli E, van der Hem JGK, van Balen P, Hoogenboom JD, de Wreede LC, Malard F, Ruggeri A, Fleischhauer K (2024)
   Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS
   Blood, 144 (16), 1747-1751
   DOI 10.1182/blood.2024024351, PubMed 39102621
6. Askeland FB, Frøen HM, Bolstad N, Thorsby PM, Schjesvold F, Wammer ACP, Følling I, Tjønnfjord GE (2024)
   Monoclonal Insulin Autoimmune Syndrome Successfully Treated With Plasma Cell Directed Therapy
   Clin Lymphoma Myeloma Leuk, 25 (3), e127-e130
   DOI 10.1016/j.clml.2024.10.005, PubMed 39500643
7. Baliakas P, Tesi B, Cammenga J, Stray-Pedersen A, Jahnukainen K, Andersen MK, Ågerstam H, Creignou M, Dybedal I, Raaschou-Jensen K, Grønbæk K, Kilpivaara O, Lindberg EH, Wartiovaara-Kautto U (2024)
   How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms
   Hemasphere, 8 (8), e145
   DOI 10.1002/hem3.145, PubMed 39139355
8. Berentsen S, Vos JMI, Malecka A, Tjønnfjord GE, D'Sa S (2024)
   The impact of individual clinical features in cold agglutinin disease: hemolytic versus non-hemolytic symptoms
   Expert Rev Hematol, 17 (8), 479-492
   DOI 10.1080/17474086.2024.2372333, PubMed 38938203
9. Brune M, Kiss T, Anderson H, Nicklasson M, Delage R, Finke J, Gedde-Dahl T, Hébert J, Höglund M, Kaare A, Lazarevic V, Möllgård L, Remes K, Ritchie D, Spyridonidis A, Sabloff M, Spearing R, Wallhult E, Ljungman P (2024)
   Reduced Intensity transplantation vs chemotherapy in CR1. A prospective, pseudorandomized study in 50-70 year old AML patients
   Bone Marrow Transplant, 59 (12), 1676-1682
   DOI 10.1038/s41409-024-02408-x, PubMed 39223244
10. Brunetti M, Andersen K, Spetalen S, Lenartova A, Osnes LTN, Vålerhaugen H, Heim S, Micci F (2024)
    NUP214 fusion genes in acute leukemias: genetic characterization of rare cases
    Front Oncol, 14, 1371980
    DOI 10.3389/fonc.2024.1371980, PubMed 38571499
11. Brunetti M, Andersen K, Trøen G, Micci F, Spetalen S, Lenartova A, Tandsæther MR, Panagopoulos I (2024)
    Molecular genetic characterization of myeloid neoplasms with idic(X)(q13) and i(X)(q10)
    Front Oncol, 14, 1428984
    DOI 10.3389/fonc.2024.1428984, PubMed 39391249
12. Chalandon Y, Eikema DJ, Moiseev I, Ciceri F, Koster L, Vydra J, Passweg J, Rovira M, Ozcelik T, Gedde-Dahl T, Kröger N, Potter V, Yakoub-Agha I, Rambaldi A, Itälä-Remes M, Tanase A, Onida F, Gurnari C, Scheid C, Drozd-Sokolowska J, Raj K, McLornan DP, Robin M (2024)
    Unrelated donor transplantation with posttransplant cyclophosphamide vs ATG for myelodysplastic neoplasms
    Blood Adv, 8 (18), 4792-4802
    DOI 10.1182/bloodadvances.2024013468, PubMed 39008719
13. Christiansen CF, Risbo N, Ghanima W, Linder M, Bahmanyar S, Seesaghur A, Clouser M, Nørgaard M, Sørensen HT (2024)
    Platelet response to romiplostim amongst patients with newly diagnosed, persistent, and chronic immune thrombocytopenia in routine clinical practice in Denmark, Sweden, and Norway
    Br J Haematol, 205 (4), 1497-1507
    DOI 10.1111/bjh.19688, PubMed 39102877
14. Cimini LA, Luijten D, Barco S, Ghanima W, Jervan Ø, Kahn SR, Konstantinides S, Lachant D, Nakano Y, Ninaber M, van Es J, van Mens T, Vonk Noordegraaf A, Becattini C, Klok FA (2024)
    Pulmonary perfusion defects or residual vascular obstruction and persistent symptoms after pulmonary embolism: a systematic review and meta-analysis
    ERJ Open Res, 10 (4)
    DOI 10.1183/23120541.01010-2023, PubMed 39076522
15. Dam M, Centanni M, Friberg LE, Centanni D, Karlsson MO, Stensig Lynggaard L, Johannsdottir IM, Wik HS, Malmros J, Vaitkeviciene GE, Griskevicius L, Hallböök H, Jónsson ÓG, Overgaard U, Schmiegelow K, Hansen SN, Heyman M, Albertsen BK (2024)
    Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia
    Leukemia, 38 (4), 712-719
    DOI 10.1038/s41375-024-02153-6, PubMed 38287133
16. Dimopoulos MA, Voorhees PM, Schjesvold F, Cohen YC, Hungria V, Sandhu I, Lindsay J, Baker RI, Suzuki K, Kosugi H, Levin MD, Beksac M, Stockerl-Goldstein K, Oriol A, Mikala G, Garate G, Theunissen K, Spicka I, Mylin AK, Bringhen S, Uttervall K, Pula B, Medvedova E, Cowan AJ, Moreau P et al. (2024)
    Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma
    N Engl J Med, 392 (18), 1777-1788
    DOI 10.1056/NEJMoa2409029, PubMed 39652675
17. Domingos V, Nezvalova-Henriksen K, Dadkhah A, Moreno-Martinez ME, Ben Hassine K, Pires V, Kröger N, Bauters T, Hassan M, Duncan N, Kalwak K, Ansari M, Langebrake C, Admiraal R (2024)
    A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT)
    Bone Marrow Transplant, 59 (12), 1641-1653
    DOI 10.1038/s41409-024-02413-0, PubMed 39271948
18. Drozd-Sokolowska J, Gras L, Koster L, Martino R, Salas MQ, Salmenniemi U, Zudaire T, Yañez L, Bellido M, Collin M, Kaufmann M, Kozlowski P, Poiré X, Ferra C, Sampol A, Wilson KMO, Cairoli A, Gedde-Dahl T, Deconinck E, Mirabile M, Suarez F, Raj K, Van Gelder M, Yakoub-Agha I, Tournilhac O et al. (2024)
    Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
    Haematologica, 109 (5), 1608-1613
    DOI 10.3324/haematol.2023.284359, PubMed 38205539
19. Fageräng B, Cyranka L, Schjalm C, McAdam KE, Larsen CS, Heinzelbecker J, Gedde-Dahl T, Würzner R, Espevik T, Tjønnfjord GE, Garred P, Barratt-Due A, Tvedt THA, Mollnes TE (2024)
    The function of the complement system remains fully intact throughout the course of allogeneic stem cell transplantation
    Front Immunol, 15, 1422370
    DOI 10.3389/fimmu.2024.1422370, PubMed 38938578
20. Flygt H, Söderlund S, Richter J, Saussele S, Koskenvesa P, Stenke L, Mustjoki S, Dimitrijevic A, Stentoft J, Majeed W, Roy L, Wolf D, Dreimane A, Gjertsen BT, Gedde-Dahl T, Ahlstrand E, Markevärn B, Hjorth-Hansen H, Janssen J, Olsson-Strömberg U (2024)
    Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial
    Leukemia, 38 (4), 781-787
    DOI 10.1038/s41375-024-02145-6, PubMed 38278960
21. Flygt H, Söderlund S, Richter J, Saussele S, Koskenvesa P, Stenke L, Mustjoki S, Dimitrijevic A, Stentoft J, Majeed W, Roy L, Wolf D, Dreimane A, Gjertsen BT, Gedde-Dahl T, Ahlstrand E, Markevärn B, Hjorth-Hansen H, Janssen J, Olsson-Strömberg U (2024)
    Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial
    Leukemia, 38 (4), 925
    DOI 10.1038/s41375-024-02184-z, PubMed 38418611
22. Giebel S, Labopin M, Peric Z, Passweg J, Blaise D, Salmenniemi U, Beauvais D, Reményi P, Chevallier P, Mielke S, Gedde-Dahl T, Cornelissen JJ, Balsat M, Bug G, Bazarbachi A, Brissot E, Nagler A, Ciceri F, Mohty M (2024)
    Impact of the Type of Tyrosine Kinase Inhibitor (imatinib or dasatinib) Used Before allo-HCT on Outcome of Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia. A Study on Behalf of the Acute Leukemia Working Party of the EBMT
    Transplant Cell Ther, 31 (1), 14.e1-14.e10
    DOI 10.1016/j.jtct.2024.07.016, PubMed 39069077
23. Gjærde LK, Brück O, Gagelmann N, Gavriilaki E, Inngjerdingen M, Keranen M, Kisch A, Myhre AE, Olivieri A, Perez-Simon JA, Perovic D, Perovic V, Piekarska A, Pulanic D, Rathje K, Van Veen S, Dachy G, Moiseev I, Penack O, Peric Z, Greinix H, Lee SJ, Wolff D, Schoemans H (2024)
    Standardized translations of the Lee Chronic GvHD Symptom Scale to 12 European languages: an EU COST Action cGvHD Eurograft project
    Bone Marrow Transplant, 59 (10), 1477-1479
    DOI 10.1038/s41409-024-02374-4, PubMed 39020019
24. Grdinic AG, Radovanovic S, Gleditsch J, Jørgensen CT, Asady E, Pettersen HH, Delibasic B, Ghanima W (2024)
    Developing a machine learning model for bleeding prediction in patients with cancer-associated thrombosis receiving anticoagulation therapy
    J Thromb Haemost, 22 (4), 1094-1104
    DOI 10.1016/j.jtha.2023.12.034, PubMed 38184201
25. Grønvold BL, Ali MM, Myklebust TÅ, Lenartova A, Remberger M, Abrahamsen IW, Tjønnfjord GE, Myhre AE, Fløisand Y, Gedde-Dahl T (2024)
    Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors
    EJHaem, 5 (1), 117-124
    DOI 10.1002/jha2.842, PubMed 38406518
26. Guièze R, Eikema DJ, Koster L, Schetelig J, Sengeloev H, Passweg J, Finke J, Arat M, Broers AEC, Stölzel F, Byrne J, Castilla-Llorente C, Dreger P, Eder M, Gedde-Dahl T, Kröger N, Ribera Santasusana JM, Richardson D, Rambaldi A, Yañez L, Van Gelder M, Drozd-Sokolowska J, Raj K, Yakoub-Agha I, Tournilhac O et al. (2024)
    Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
    Bone Marrow Transplant, 59 (7), 950-956
    DOI 10.1038/s41409-024-02256-9, PubMed 38503942
27. Halstensen TD, Hardeland C, Ghanima W, Grøndahl VA, Hubin A, Tavoly M (2024)
    Development and internal validation of a simple clinical score for the estimation of the probability of deep vein thrombosis in outpatient emergency department patients
    Res Pract Thromb Haemost, 8 (8), 102608
    DOI 10.1016/j.rpth.2024.102608, PubMed 39717281
28. Halvorsen B, Viermyr HK, Ueland T, Sagen EL, Michelsen AE, Bjerkeli V, Nor-Solidarity Study Group, Tveita AA, Henriksen KN, Kåsine T, Dyrhol-Riise AM, Trøseid M, Dahl TB, Aukrust P, Gregersen I (2024)
    IL-22 is increased in hospitalized patients with COVID-19 and associates with cardiac involvement
    J Infect, 89 (1), 106176
    DOI 10.1016/j.jinf.2024.106176, PubMed 38719108
29. Hamnvik LHD, Eide-Olsen S, Fosseng A, Schjesvold FH (2024)
    Estimated Financial Savings From Clinical Studies at Oslo Myeloma Center in the Period 2015-2021
    Clin Lymphoma Myeloma Leuk, 25 (1), e62-e69
    DOI 10.1016/j.clml.2024.07.015, PubMed 39191633
30. Hamnvik LHD, Tjønnfjord GE, Spetalen S, Dalgaard J (2024)
    Long-lasting severe anemia following treatment with natalizumab for relapsing-remitting multiple sclerosis: a case report
    J Med Case Rep, 18 (1), 245
    DOI 10.1186/s13256-024-04562-8, PubMed 38736000
31. Harrison SP, Baumgarten SF, Chollet ME, Stavik B, Bhattacharya A, Almaas R, Sullivan GJ (2024)
    Parenteral nutrition emulsion inhibits CYP3A4 in an iPSC derived liver organoids testing platform
    J Pediatr Gastroenterol Nutr, 78 (5), 1047-1058
    DOI 10.1002/jpn3.12195, PubMed 38529852
32. Haukeland-Parker S, Jervan Ø, Ghanima W, Spruit MA, Holst R, Tavoly M, Gleditsch J, Johannessen HH (2024)
    Physical activity following pulmonary embolism and clinical correlates in selected patients: a cross-sectional study
    Res Pract Thromb Haemost, 8 (2), 102366
    DOI 10.1016/j.rpth.2024.102366, PubMed 38562511
33. Holland P, Istre M, Ali MM, Gedde-Dahl T, Buechner J, Wildhagen M, Brunvoll SH, Horvath S, Matsuyama S, Dahl JA, Stölzel F, Søraas A (2024)
    Epigenetic aging of human blood cells is influenced by the age of the host body
    Aging Cell, 23 (5), e14112
    DOI 10.1111/acel.14112, PubMed 38439206
34. Holm S, Michelsen AE, Schultz NH, Ueland T, Reikvam H, Holme PA, Aukrust P, Halvorsen B (2024)
    Human papilloma virus vaccine induced thrombocytopenia accompanied by a wide spectrum of reversible inflammatory responses - a case report
    Scand J Clin Lab Invest, 84 (6), 425-427
    DOI 10.1080/00365513.2024.2400663, PubMed 39264796
35. Holme PA, Blatný J, Chowdary P, Lassila R, O'Connell N, Hermans C, Álvarez Román MT, Négrier C, Coppola A, Oldenburg J (2024)
    Moving towards Normalization of haemostasis and health equity: Evolving treatment goals for haemophilia A
    Haemophilia, 30 (5), 1109-1114
    DOI 10.1111/hae.15031, PubMed 38986684
36. Holme PA, Poulsen LH, Tueckmantel C, Maas Enriquez M, Alvarez Román MT, De Cristofaro R (2024)
    Safety and efficacy of damoctocog alfa pegol prophylaxis in patients with severe haemophilia A: Results of an interventional, post-marketing study
    Haemophilia, 30 (2), 388-394
    DOI 10.1111/hae.14930, PubMed 38229269
37. Imbery JF, Wiik C, Heinzelbecker J, Jebsen JK, Dobbing MK, Bottini N, Stanford SM, Munthe LA, Tjønnfjord GE, Tveita A, Szodoray P, Nakken B (2024)
    CD38 regulates chronic lymphocytic leukemia proliferation via CD45 phosphatase activity
    Mol Ther Oncol, 32 (3), 200841
    DOI 10.1016/j.omton.2024.200841, PubMed 39474602
38. Iversen PO, Gueant JL, Oussalah A, Refsum H, Nexo E, Tjønnfjord GE, Qvigstad C (2024)
    Heterozygous Mutations in Both the AMN and CBS Genes: Double Haploinsufficiency as an Unusual Cause of Vitamin B₁₂ Deficiency-A Case Report
    Clin Case Rep, 12 (11), e9600
    DOI 10.1002/ccr3.9600, PubMed 39582727
39. Kakwangire P, Atukunda P, Ngari M, Westerberg AC, Iversen PO, Muhoozi G (2024)
    Long-term effects on depressive symptoms among Ugandan mothers - Findings from a follow-up of a cluster-randomized education trial in a rural low-resource setting
    J Affect Disord, 351, 598-606
    DOI 10.1016/j.jad.2024.01.263, PubMed 38307132
40. Kakwangire P, Muhoozi G, Ngari M, Matovu N, Westerberg AC, Iversen PO, Atukunda P (2024)
    8-Year Follow-up of a Maternal Education Trial in a Low-Resource Setting
    Pediatrics, 153 (4)
    DOI 10.1542/peds.2023-063352, PubMed 38505933
41. Kakwangire P, Ngari M, Muhoozi G, Westerberg AC, Atukunda P, Iversen PO (2024)
    Associations between sociodemographic exposures, growth and development during infancy with development at the age of eight years among children: Analysis of a maternal education trial in rural Uganda
    J Glob Health, 14, 04228
    DOI 10.7189/jogh.14.04228, PubMed 39641314
42. Kamudoni PR, Kaunda L, Tharrey M, Mphande M, Chithambo S, Ferguson E, Shi Z, Mdala I, Maleta K, Munthali A, Holmboe-Ottesen G, Iversen PO (2024)
    Context-Tailored Food-Based Nutrition Education and Counseling for Pregnant Women to Improve Birth Outcomes: A Cluster-Randomized Controlled Trial in Rural Malawi
    Curr Dev Nutr, 8 (12), 104506
    DOI 10.1016/j.cdnut.2024.104506, PubMed 39654971
43. Kardel KR, Iversen PO, Kaaya AN, Muhoozi G, Veierød MB, Wangen KR, Børøsund E, Friberg PA (2024)
    A pragmatic randomized trial to examine the effect of combining healthy diet with mindfulness cognitive therapy to reduce depressive symptoms among university students in a low-resource setting: protocol for the NutriMind Project
    BMC Psychiatry, 24 (1), 610
    DOI 10.1186/s12888-024-06056-9, PubMed 39261786
44. Kleftogiannis D, Gavasso S, Tislevoll BS, van der Meer N, Motzfeldt IKF, Hellesøy M, Gullaksen SE, Griessinger E, Fagerholt O, Lenartova A, Fløisand Y, Schuringa JJ, Gjertsen BT, Jonassen I (2024)
    Automated cell type annotation and exploration of single-cell signaling dynamics using mass cytometry
    iScience, 27 (7), 110261
    DOI 10.1016/j.isci.2024.110261, PubMed 39021803
45. Koroma AS, Stephenson KB, Iversen PO, Manary MJ, Hendrixson DT (2024)
    The Effect of Breastfeeding Practices of Undernourished Mothers in Rural Sierra Leone on Infant Growth and Mortality
    Children (Basel), 11 (2)
    DOI 10.3390/children11020233, PubMed 38397345
46. Lin Y, Qiu L, Usmani S, Joo CW, Costa L, Derman B, Du J, Einsele H, Fernandez de Larrea C, Hajek R, Ho PJ, Kastritis E, Martinez-Lopez J, Mateos MV, Mikhael J, Moreau P, Nagarajan C, Nooka A, O'Dwyer M, Schjesvold F, Sidana S, van de Donk NW, Weisel K, Zweegman S, Raje N et al. (2024)
    Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee
    Lancet Oncol, 25 (8), e374-e387
    DOI 10.1016/S1470-2045(24)00094-9, PubMed 38821074
47. Loke J, Labopin M, Craddock C, Socié G, Gedde-Dahl T, Blaise D, Forcade E, Salmenniemi U, Huynh A, Versluis J, Yakoub-Agha I, Labussière-Wallet H, Maertens J, Passweg J, Bulabois CE, Gabellier L, Mielke S, Castilla-Llorente C, Deconinck E, Brissot E, Nagler A, Ciceri F, Mohty M (2024)
    Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation study
    Cancer, 130 (15), 2642-2651
    DOI 10.1002/cncr.35308, PubMed 38581695
48. Lund T, Gundesen MT, Juul Vangsted A, Helleberg C, Haukås E, Silkjær T, Asmussen JT, Manuela Teodorescu E, Amdi Jensen B, Schmidt Slørdahl T, Nahi H, Waage A, Abildgaard N, Schjesvold F, Nordic Myeloma Study Group (2024)
    In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease
    Blood Cancer J, 14 (1), 65
    DOI 10.1038/s41408-024-01046-2, PubMed 38622134
49. Małecka A, Østlie I, Trøen G, Małecki J, Delabie J, Tierens A, Munthe LA, Berentsen S, Tjønnfjord GE (2024)
    Gene expression analysis revealed downregulation of complement receptor 1 in clonal B cells in cold agglutinin disease
    Clin Exp Immunol, 216 (1), 45-54
    DOI 10.1093/cei/uxad135, PubMed 38133636
50. McDonald GB, Landsverk OJB, McGovern DPB, Aasebø A, Paulsen V, Haritunians T, Reims HM, McLaughlin BM, Zisman T, Li D, Elholm ETMM, Jahnsen FL, Georges GE, Gedde-Dahl T (2024)
    Allogeneic bone marrow transplantation for patients with treatment-refractory Crohn's Disease
    Heliyon, 10 (1), e24026
    DOI 10.1016/j.heliyon.2024.e24026, PubMed 38283244
51. Mohty R, Bazarbachi AH, Labopin M, Esteve J, Kröger N, Cornelissen JJ, Blaise D, Socié G, Maury S, Ganser A, Gedde-Dahl T, von dem Borne P, Bourhis JH, Bulabois CE, Yakoub-Agha I, Pabst C, Nguyen S, Chevallier P, Huynh A, Bazarbachi A, Nagler A, Ciceri F, Mohty M (2024)
    Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMT
    Bone Marrow Transplant, 59 (11), 1534-1541
    DOI 10.1038/s41409-024-02384-2, PubMed 39143183
52. Montoro J, Eikema DJ, Tuffnell J, Potter V, Kalwak K, Halkes CJM, Kulagin A, Collin M, Wynn RF, Robinson S, Nicholson E, Sengeloev H, Clay J, Halahleh K, Skorobogatova E, Sanz J, Passweg J, Mielke S, Ryhänen S, Carpenter B, Gedde-Dahl T, Tholouli E, Fanin R, Lewalle P, Kulasekararaj A et al. (2024)
    Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT
    Blood, 144 (3), 323-333
    DOI 10.1182/blood.2024024173, PubMed 38643511
53. Moukalled N, Labopin M, Versluis J, Socié G, Blaise D, Salmenniemi U, Rambaldi A, Gedde-Dahl T, Tholouli E, Kröger N, Bourhis JH, Von Dem Borne P, Daguindau E, Forcade E, Nagler A, Esteve J, Ciceri F, Bazarbachi A, Mohty M (2024)
    Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1-mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party
    Am J Hematol, 99 (3), 360-369
    DOI 10.1002/ajh.27187, PubMed 38165072
54. Måseide RJ, Berntorp E, Astermark J, Olsson A, Bruzelius M, Frisk T, Nummi V, Lassila R, Strandberg K, Tjønnfjord GE, Holme PA (2024)
    Nonneutralizing antibodies in Nordic persons with moderate hemophilia A and B (the MoHem study)
    Res Pract Thromb Haemost, 8 (8), 102611
    DOI 10.1016/j.rpth.2024.102611, PubMed 39807249
55. Nagler A, Labopin M, Swoboda R, Schroeder T, Hamladji RM, Griskevicius L, Salmenniemi U, Rambaldi A, Mielke S, Kulagin A, Passweg J, Luft T, Gedde-Dahl T, Forcade E, Helbig G, Stelljes M, Castilla-Llorente C, Spyridonidis A, Brissot E, Ciceri F, Mohty M (2024)
    Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Bone Marrow Transplant, 59 (7), 1012-1021
    DOI 10.1038/s41409-024-02284-5, PubMed 38615143
56. Nagler A, Ngoya M, Galimard JE, Labopin M, Blau IW, Kröger N, Gedde-Dahl T, Schroeder T, Burns D, Salmenniemi U, Rambaldi A, Choi G, Peffault de Latour R, Vydra J, Sengeloev H, Eder M, Mielke S, Forcade E, Kulagin A, Ciceri F, Mohty M (2024)
    Comparable relapse incidence after unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide versus conventional anti-graft versus host disease prophylaxis in patients with acute myeloid leukemia: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Am J Hematol, 99 (9), 1732-1745
    DOI 10.1002/ajh.27383, PubMed 38856236
57. Ngari M, Mwangome M, Ouma N, Nyaguara A, Mturi N, Obiero C, Kamau A, Walson JL, Iversen PO, Maitland K, Snow RW, Berkley J (2024)
    Inpatient and postdischarge mortality among children with anaemia and malaria parasitaemia in Kenya: a cohort study
    BMJ Glob Health, 9 (10)
    DOI 10.1136/bmjgh-2024-016600, PubMed 39433400
58. Nielsen LK, Schjesvold F, Möller S, Guldbrandsen N, Hansson M, Remes K, Peceliunas V, Abildgaard N, Gregersen H, King MT (2024)
    Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: a randomized phase 2 trial by the Nordic Myeloma Study Group
    J Patient Rep Outcomes, 8 (1), 15
    DOI 10.1186/s41687-024-00691-2, PubMed 38315268
59. Nørgaard JN, Moore KLF, Slørdahl TS, Vik A, Tvedt THA, Schjesvold F (2024)
    VRD versus VCD as induction therapy before autologous stem cell transplantation in multiple myeloma: a nationwide population-based study
    Blood Cancer J, 14 (1), 60
    DOI 10.1038/s41408-024-01047-1, PubMed 38594252
60. Oldenburg J, Hay C, Peyvandi F, Tagliaferri A, Holme PA, Álvarez-Román MT, Biron-Andréani C, Malmström H, Bystrická L, Lethagen S, A‐SURE Study Group (2024)
    Superior Prophylactic Effectiveness of a Recombinant FVIIIFc Over Standard Half-Life FVIII in Hemophilia A: A-SURE Study
    Eur J Haematol, 114 (2), 248-257
    DOI 10.1111/ejh.14309, PubMed 39434416
61. Panagopoulos I, Andersen K, Stavseth V, Torkildsen S, Heim S, Tandsæther MR (2024)
    Germline MYOF1::WNK4 and VPS25::MYOF1 Chimeras Generated by the Constitutional Translocation t(17;19)(q21;p13) in Two Siblings With Myelodysplastic Syndrome
    Cancer Genomics Proteomics, 21 (3), 272-284
    DOI 10.21873/cgp.20446, PubMed 38670586
62. Panagopoulos I, Andersen K, Wik HS, Tandsæther MR (2024)
    Acute Lymphoblastic Leukemia With Near-haploid Karyotype and Philadelphia Chromosome
    Anticancer Res, 44 (4), 1389-1397
    DOI 10.21873/anticanres.16935, PubMed 38537997
63. Partanen A, Waage A, Peceliunas V, Schjesvold F, Anttila P, Säily M, Uttervall K, Putkonen M, Carlson K, Haukas E, Sankelo M, Szatkowski D, Hansson M, Marttila A, Svensson R, Axelsson P, Lauri B, Mikkola M, Karlsson C, Abelsson J, Ahlstrand E, Sikiö A, Klimkowska M, Matuzeviciene R, Fenstad MH et al. (2024)
    Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group
    Cancers (Basel), 16 (5)
    DOI 10.3390/cancers16051024, PubMed 38473382
64. Patrick-Brown TDJH, Barratt-Due A, Trøseid M, Dyrhol-Riise AM, Nezvalova-Henriksen K, Kåsine T, Aukrust P, Olsen IC, NOR Solidarity consortium (2024)
    The effects of remdesivir on long-term symptoms in patients hospitalised for COVID-19: a pre-specified exploratory analysis
    Commun Med (Lond), 4 (1), 231
    DOI 10.1038/s43856-024-00650-4, PubMed 39533001
65. Pawlyn C, Schjesvold FH, Cairns DA, Wei LJ, Davies F, Nadeem O, Abdulhaq H, Mateos MV, Laubach J, Weisel K, Ludwig H, Rajkumar SV, Sonneveld P, Jackson G, Morgan G, Richardson PG (2024)
    Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm
    Blood Cancer J, 14 (1), 134
    DOI 10.1038/s41408-024-01109-4, PubMed 39134544
66. Penack O, Abouqateb M, Peczynski C, Boreland W, Gülbas Z, Gedde-Dahl T, Castilla-Llorente C, Kröger N, Eder M, Rambaldi A, Bonifazi F, Blau IW, Stelljes M, Dreger P, Moiseev I, Schoemans H, Koenecke C, Peric Z (2024)
    PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation
    Blood Cancer J, 14 (1), 45
    DOI 10.1038/s41408-024-01032-8, PubMed 38485723
67. Penack O, Abouqateb M, Peczynski C, Boreland W, Kröger N, Stelljes M, Gedde-Dahl T, Blau IW, Schroeder T, Salmenniemi U, Kulagin A, Peffault de Latour R, Mielke S, Zeiser R, Moiseev I, Schoemans H, Koenecke C, Peric Z (2024)
    ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?
    Leukemia, 38 (5), 1156-1163
    DOI 10.1038/s41375-024-02225-7, PubMed 38538862
68. Podgorica M, Drivet E, Viken JK, Richman A, Vestbøstad J, Szodoray P, Kvam AK, Wik HS, Tjønnfjord GE, Munthe LA, Frietze S, Schjerven H (2024)
    Transcriptome analysis of primary adult B-cell lineage acute lymphoblastic leukemia identifies pathogenic variants and gene fusions, and predicts subtypes for in depth molecular diagnosis
    Eur J Haematol, 112 (5), 731-742
    DOI 10.1111/ejh.14164, PubMed 38192186
69. Pour L, Szarejko M, Bila J, Schjesvold FH, Spicka I, Maisnar V, Jurczyszyn A, Grudeva-Popova Z, Hájek R, Usenko G, Thuresson M, Norin S, Jarefors S, Bakker NA, Richardson PG, Mateos MV (2024)
    Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study
    Haematologica, 109 (3), 895-905
    DOI 10.3324/haematol.2023.283509, PubMed 37646660
70. Qvigstad C, Sørensen LQ, Tjønnfjord GE, Holme PA, Age-related DeVelopments ANd ComorbiditiEs in hemophilia Working Group (2024)
    The association between unemployment and treatment among adults with hemophilia
    Res Pract Thromb Haemost, 8 (5), 102514
    DOI 10.1016/j.rpth.2024.102514, PubMed 39188890
71. Reding MT, Lalezari S, Kenet G, Di Minno G, Ducore J, Solms A, Shah A, Holme PA, Poulsen LH, Meijer K, Simpson M, Mancuso ME (2024)
    Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review
    Drugs R D, 24 (3), 359-381
    DOI 10.1007/s40268-024-00481-7, PubMed 39162954
72. Reding MT, Lalezari S, Kenet G, Di Minno G, Ducore J, Solms A, Shah A, Holme PA, Poulsen LH, Meijer K, Simpson M, Mancuso ME (2024)
    Correction: Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review
    Drugs R D, 25 (1), 89-98
    DOI 10.1007/s40268-024-00494-2, PubMed 39702563
73. Reding MT, Simpson M, Ducore J, Holme PA, Maas Enriquez M, Mancuso ME (2024)
    Long-Term Efficacy and Safety of Damoctocog Alfa Pegol Prophylaxis in Patients with Haemophilia A Aged 12-<18 Years at Enrolment into PROTECT VIII
    Acta Haematol, 148 (1), 58-67
    DOI 10.1159/000538702, PubMed 38599195
74. Richardson PG, Perrot A, Miguel JS, Beksac M, Spicka I, Leleu X, Schjesvold F, Moreau P, Dimopoulos MA, Huang SY, Minarik J, Cavo M, Prince HM, Macé S, Zhang R, Dubin F, Morisse MC, Anderson KC (2024)
    Isatuximab-pomalidomide-dexamethasone versus pomalidomide-dexamethasone in patients with relapsed and refractory multiple myeloma: final overall survival analysis
    Haematologica, 109 (7), 2239-2249
    DOI 10.3324/haematol.2023.284325, PubMed 38299578
75. Rodriguez-Otero P, Usmani S, Cohen AD, van de Donk NWCJ, Leleu X, Gállego Pérez-Larraya J, Manier S, Nooka AK, Mateos MV, Einsele H, Minnema M, Cavo M, Derman BA, Puig N, Gay F, Ho PJ, Chng WJ, Kastritis E, Gahrton G, Weisel K, Nagarajan C, Schjesvold F, Mikhael J, Costa L, Raje NS et al. (2024)
    International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma
    Lancet Oncol, 25 (5), e205-e216
    DOI 10.1016/S1470-2045(24)00043-3, PubMed 38697166
76. Rogn Å, Jensen JL, Iversen PO, Singh PB (2024)
    Post-COVID-19 patients suffer from chemosensory, trigeminal, and salivary dysfunctions
    Sci Rep, 14 (1), 3455
    DOI 10.1038/s41598-024-53919-y, PubMed 38342941
77. Rogn Å, Jensen JL, Iversen PO, Singh PB (2024)
    Publisher Correction: Post-COVID-19 patients suffer from chemosensory, trigeminal, and salivary dysfunctions
    Sci Rep, 14 (1), 9213
    DOI 10.1038/s41598-024-59915-6, PubMed 38649502
78. Rosenberg T, Möller S, Abildgaard N, Nørgaard JN, Lysén A, Tsykonova G, Joao C, Vangsted A, Schjesvold F, Nielsen LK (2024)
    Health-Related Quality of Life During Carfilzomib-Lenalidomide-Dexamethasone Consolidation: Findings From the Multiple Myeloma CONPET Study
    Eur J Haematol, 114 (3), 517-527
    DOI 10.1111/ejh.14358, PubMed 39638553
79. Røed-Undlien H, Schultz NH, Amundsen EK, Wollmann BM, Molden E, Akerkar RR, Bjørnstad JL (2024)
    Does in vitro hemolysis affect measurements of plasma apixaban concentration by UPLC-MS and anti-Xa assay?
    Int J Lab Hematol, 46 (5), 946-952
    DOI 10.1111/ijlh.14311, PubMed 38808488
80. Røed-Undlien H, Schultz NH, Husebråten IM, Wollmann BM, Akerkar RR, Molden E, Amundsen EK, Bjørnstad JL (2024)
    Apixaban removal during emergency surgery for type A acute aortic dissection: a prospective cohort study
    Int J Surg, 110 (12), 7782-7790
    DOI 10.1097/JS9.0000000000002137, PubMed 39806740
81. Røed-Undlien H, Schultz NH, Lunnan A, Husebråten IM, Wollmann BM, Molden E, Bjørnstad JL (2024)
    Corrigendum to < IN-VITRO APIXABAN REMOVAL BY CYTOSORB® WHOLE BLOOD ADSORBER. AN EXPERIMENTAL STUDY.> <[Journal of Cardiothoracic and Vascular Anesthesia 36/6 (2024) 1636 - 1644]>
    J Cardiothorac Vasc Anesth, 38 (7), 1606-1607
    DOI 10.1053/j.jvca.2024.03.039, PubMed 38580477
82. Røra M, Solberg MS, Moore KLF, Slørdahl TS (2024)
    Incidence and prevention of skeletal-related events in multiple myeloma patients: A population-based real-world experience
    EJHaem, 5 (4), 669-676
    DOI 10.1002/jha2.928, PubMed 39157600
83. Rørvik SD, Torkildsen S, Bruserud Ø, Tvedt THA (2024)
    Acute myeloid leukemia with rare recurring translocations-an overview of the entities included in the international consensus classification
    Ann Hematol, 103 (4), 1103-1119
    DOI 10.1007/s00277-024-05680-5, PubMed 38443661
84. Scheid C, Eikema DJ, van Gelder M, Salmenniemi U, Maertens J, Passweg J, Blaise D, Byrne JL, Kröger N, Sockel K, Chevallier P, Bourhis JH, Cornelissen JJ, Sengeloev H, Finke J, Snowden JA, Gedde-Dahl T, Cornillon J, Schanz U, Patel A, Koster L, de Wreede LC, Hayden P, Raj K, Drozd-Sokolowska J et al. (2024)
    Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms?
    Blood, 144 (4), 445-456
    DOI 10.1182/blood.2023022273, PubMed 38728380
85. Schjesvold FH, Ludwig H, Delimpasi S, Robak P, Coriu D, Tomczak W, Pour L, Spicka I, Dimopoulos MA, Masszi T, Chernova NG, Sandberg A, Thuresson M, Norin S, Bakker NA, Mateos MV, Richardson PG, Sonneveld P (2024)
    Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study
    Haematologica, 109 (7), 2331-2336
    DOI 10.3324/haematol.2023.284635, PubMed 38426292
86. Sefland Ø, Gullaksen SE, Omsland M, Reikvam H, Galteland E, Tran HTT, Spetalen S, Singh SK, Van Zeeburg HJT, Van De Loosdrecht AA, Gjertsen BT (2024)
    Mass cytometric single cell immune profiles of peripheral blood from acute myeloid leukemia patients in complete remission with measurable residual disease
    Cytometry B Clin Cytom, 106 (6), 485-496
    DOI 10.1002/cyto.b.22197, PubMed 39078053
87. Shaw JR, Nopp S, Stavik B, Youkhana K, Michels AL, Kennes S, Rak J, Ten Cate H (2024)
    Thrombosis, Translational Medicine, and Biomarker Research: Moving the Needle
    J Am Heart Assoc, 14 (1), e038782
    DOI 10.1161/JAHA.124.038782, PubMed 39719414
88. Sletten M, Skogstrøm KB, Lind SM, Tinholt M, Stavik B, Rayner S, Iversen N (2024)
    Elevated TFPI is a prognostic factor in hepatocellular carcinoma: Putative role of miR-7-5p and miR-1236-3p
    Thromb Res, 241, 109073
    DOI 10.1016/j.thromres.2024.109073, PubMed 38945092
89. Sonneveld P, Dimopoulos MA, Boccadoro M, Quach H, Ho PJ, Beksac M, Hulin C, Antonioli E, Leleu X, Mangiacavalli S, Perrot A, Cavo M, Belotti A, Broijl A, Gay F, Mina R, van de Donk NWCJ, Katodritou E, Schjesvold F, Balari AS, Rosiñol L, Delforge M, Roeloffzen W, Silzle T, Vangsted A et al. (2024)
    A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myeloma
    Future Oncol, 20 (38), 3043-3063
    DOI 10.1080/14796694.2024.2394323, PubMed 39287147
90. Stevanovic S, Dalmao-Fernandez A, Mohamed D, Nyman TA, Kostovski E, Iversen PO, Savikj M, Nikolic N, Rustan AC, Thoresen GH, Kase ET (2024)
    Time-dependent reduction in oxidative capacity among cultured myotubes from spinal cord injured individuals
    Acta Physiol (Oxf), 240 (7), e14156
    DOI 10.1111/apha.14156, PubMed 38711362
91. Styczynski J, Tridello G, Knelange N, Wendel L, Ljungman P, Mikulska M, Gil L, Cesaro S, Averbuch D, von dem Borne P, Xhaard A, Mielke S, Neven B, Snowden JA, Dalle JH, Rubio MT, Crawley C, Maertens J, Kuball J, Chevallier P, Michel G, Gabriel M, Burns D, Wynn RF, Renard C et al. (2024)
    Adenovirus infections after allogeneic hematopoietic cell transplantation in children and adults: a study from the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation
    Bone Marrow Transplant, 59 (10), 1402-1412
    DOI 10.1038/s41409-024-02361-9, PubMed 38987308
92. Tinholt M, Tekpli X, Torland LA, Tahiri A, Geisler J, Kristensen V, Sandset PM, Iversen N (2024)
    The breast cancer coagulome in the tumor microenvironment and its role in prognosis and treatment response to chemotherapy
    J Thromb Haemost, 22 (5), 1319-1335
    DOI 10.1016/j.jtha.2024.01.003, PubMed 38237862
93. Tobiasson M, Pandzic T, Illman J, Nilsson L, Weström S, Ejerblad E, Olesen G, Björklund A, Olsnes Kittang A, Werlenius O, Lorentz F, Rasmussen B, Cammenga J, Weber D, Lindholm C, Wiggh J, Dimitriou M, Moen AE, Yip Lundström L, von Bahr L, Baltzer-Sollander K, Jädersten M, Kytölä S, Walldin G, Ljungman P et al. (2024)
    Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation
    J Clin Oncol, 42 (12), 1378-1390
    DOI 10.1200/JCO.23.01159, PubMed 38232336
94. van der Maas NG, Versluis J, Nasserinejad K, van Rosmalen J, Pabst T, Maertens J, Breems D, Manz M, Cloos J, Ossenkoppele GJ, Floisand Y, Gradowska P, Löwenberg B, Huls G, Postmus D, Pignatti F, Cornelissen JJ (2024)
    Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial
    Blood Cancer J, 14 (1), 56
    DOI 10.1038/s41408-024-01037-3, PubMed 38538587
95. Vethe NT, Andersen AM, Gedde-Dahl T, Büchner J, Bergan S (2024)
    Therapeutic Drug Monitoring of Intravenous Busulfan and Analytical Challenges due to the Drug Formulation Excipient PEG 400: Letter to the Editor
    Ther Drug Monit, 46 (3), 416-417
    DOI 10.1097/FTD.0000000000001209, PubMed 38648662
96. Viermyr HK, Halvorsen B, Sagen EL, Michelsen AE, Barrat-Due A, Kåsine T, Nezvalova-Henriksen K, Dyrhol-Riise AM, Nor‐Solidarity Consortium, Lerum TV, Müller F, Tonby K, Tveita A, Aukrust P, Trøseid M, Ueland T, Dahl TB (2024)
    High viral loads combined with inflammatory markers predict disease severity in hospitalized COVID-19 patients: Results from the NOR-Solidarity trial
    J Intern Med, 296 (3), 249-259
    DOI 10.1111/joim.13820, PubMed 39011800
97. Wang HL, Siow R, Schmauck-Medina T, Zhang J, Sandset PM, Filshie C, Lund Ø, Partridge L, Bergersen LH, Juel Rasmussen L, Palikaras K, Sotiropoulos I, Storm-Mathisen J, Rubinsztein DC, Spillantini MG, De Zeeuw CI, Watne LO, Vyhnalek M, Veverova K, Liang KX, Tavernarakis N, Bohr VA, Yokote K, Saarela J, Nilsen H et al. (2024)
    Meeting Summary of The NYO3 5th NO-Age/AD Meeting and the 1st Norway-UK Joint Meeting on Aging and Dementia: Recent Progress on the Mechanisms and Interventional Strategies
    J Gerontol A Biol Sci Med Sci, 79 (4)
    DOI 10.1093/gerona/glae029, PubMed 38289789
98. Wang J, Sufar EK, Bernhoft A, Seal C, Rempelos L, Hasanaliyeva G, Zhao B, Iversen PO, Baranski M, Volakakis N, Leifert C (2024)
    Mycotoxin contamination in organic and conventional cereal grain and products: A systematic literature review and meta-analysis
    Compr Rev Food Sci Food Saf, 23 (3), e13363
    DOI 10.1111/1541-4337.13363, PubMed 38720588
99. Westerberg NS, Atneosen-Åsegg M, Melheim M, Chollet ME, Harrison SP, Siller R, Sullivan GJ, Almaas R (2024)
    Effect of hypoxia on aquaporins and hepatobiliary transport systems in human hepatic cells
    Pediatr Res, 97 (1), 195-201
    DOI 10.1038/s41390-024-03368-0, PubMed 38951656
100. Ye Y, Labopin M, Chen J, Wu D, Gedde-Dahl T, Blaise D, Socie G, Forcade E, Salmenniemi U, Maury S, Versluis J, Bazarbachi A, Nagler A, Brissot E, Li L, Luo Y, Shi J, Ciceri F, Huang H, Mohty M, Gorin NC (2024)
     Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT
     Blood Cancer J, 14 (1), 85
     DOI 10.1038/s41408-024-01072-0, PubMed 38802349
101. Ye Y, Labopin M, Gérard S, Yakoub-Agha I, Blau IW, Aljurf M, Forcade E, Gedde-Dahl T, Burns D, Vydra J, Halahleh K, Hamladji RM, Bazarbachi A, Nagler A, Brissot E, Li L, Luo Y, Zhao Y, Ciceri F, Huang H, Mohty M, Gorin NC (2024)
     Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core-binding factor AML patients in CR2: A study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
     Am J Hematol, 99 (7), 1290-1299
     DOI 10.1002/ajh.27342, PubMed 38654658
102. Zaboras Z, Jørgensen CT, Stensvold A, Pettersen HH, Grdinic AG, Brækkan SK, Ghanima W, Tavoly M (2024)
     Real-world Data on Treatment Patterns and Bleeding in Cancer-associated Thrombosis: Data from the TROLL Registry
     TH Open, 8 (1), e132-e140
     DOI 10.1055/s-0044-1782219, PubMed 38532938
103. Aarstad HH, Moe SEE, Lybak S, Bruserud Ø, Tvedt THA, Aarstad HJ (2024)
     Plasma IL-1 and IL-6 Family Cytokines with Soluble Receptor Levels at Diagnosis in Head and Neck Squamous Cell Carcinoma: High Levels Predict Decreased Five-Year Disease-Specific and Overall Survival
     Cancers (Basel), 16 (8)
     DOI 10.3390/cancers16081484, PubMed 38672565

Publications 2023

1. Ahmed M, Muhoozi GKM, Atukunda P, Westerberg AC, Iversen PO, Wangen KR (2023)
   Cognitive development among children in a low-income setting: Cost-effectiveness analysis of a maternal nutrition education intervention in rural Uganda
   PLoS One, 18 (8), e0290379
   DOI 10.1371/journal.pone.0290379, PubMed 37594989
2. Al Hamed R, Ngoya M, Galimard JE, Sengeloev H, Gedde-Dahl T, Kulagin A, Platzbecker U, Yakoub-Agha I, Byrne JL, Valerius T, Socie G, Kröger N, Blaise D, Bazarbachi A, Sanz J, Ciceri F, Nagler A, Mohty M (2023)
   Unrelated or haploidentical allogeneic hematopoietic cell transplantation in second complete remission for acute myeloid leukemia-Improved outcomes over time: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party study
   Cancer, 129 (17), 2645-2654
   DOI 10.1002/cncr.34843, PubMed 37269074
3. Ali MM, Gedde-Dahl T, Osnes LT, Perrier F, Veierød MB, Tjønnfjord GE, Iversen PO (2023)
   Extracorporeal Photopheresis as Graft-versus-Host Disease Prophylaxis: A Randomized Controlled Trial
   Transplant Cell Ther, 29 (6), 364.e1-364.e11
   DOI 10.1016/j.jtct.2023.02.023, PubMed 36878428
4. Andersen AN, Brodersen AM, Ayuda-Durán P, Piechaczyk L, Tadele DS, Baken L, Fredriksen J, Stoksflod M, Lenartova A, Fløisand Y, Skånland SS, Enserink JM (2023)
   Clinical forecasting of acute myeloid leukemia using ex vivo drug-sensitivity profiling
   Cell Rep Methods, 3 (12), 100654
   DOI 10.1016/j.crmeth.2023.100654, PubMed 38065095
5. Arnold DM, Clerici B, Ilicheva E, Ghanima W (2023)
   Refractory immune thrombocytopenia in adults: Towards a new definition
   Br J Haematol, 203 (1), 23-27
   DOI 10.1111/bjh.19075, PubMed 37642211
6. Arvanitakis A, Holme PA, Berntorp E, Astermark J (2023)
   Impact of timing of prophylaxis commencement, F8 genotype and age on factor consumption and health-related quality of life in patients with severe haemophilia A
   Haemophilia, 29 (4), 1032-1038
   DOI 10.1111/hae.14806, PubMed 37252898
7. Astermark J, Baghaei F, Strandberg K, Toplican PG, Birkedal MF, Grahn EE, Hansson C, Kampmann P, Lehtinen AE, Täckström K, Holme PA, Magnusson M (2023)
   Infrastructural considerations of implementing gene therapy for hemophilia in the Nordic context
   Ther Adv Hematol, 14, 20406207231202306
   DOI 10.1177/20406207231202306, PubMed 37859645
8. Ayuda-Durán P, Hermansen JU, Giliberto M, Yin Y, Hanes R, Gordon S, Kuusanmäki H, Brodersen AM, Andersen AN, Taskén K, Wennerberg K, Enserink JM, Skånland SS (2023)
   Standardized assays to monitor drug sensitivity in hematologic cancers
   Cell Death Discov, 9 (1), 435
   DOI 10.1038/s41420-023-01722-5, PubMed 38040674
9. Bach-Gansmo T, Hodt A, Schjesvold FH, Gude E, Wien TN (2023)
   Bone scintigraphy reduces the need for biopsy in suspected cardiac amyloidosis
   Tidsskr Nor Laegeforen, 143 (9)
   DOI 10.4045/tidsskr.22.0644, PubMed 37341415
10. Bazarbachi A, Labopin M, Gedde-Dahl T, Remenyi P, Forcade E, Kröger N, Socié G, Craddock C, Bourhis JH, Versluis J, Yakoub-Agha I, Salmenniemi U, El-Cheikh J, Bug G, Esteve J, Nagler A, Ciceri F, Mohty M (2023)
    Improved Posttransplant Outcomes in Recent Years for AML Patients with FLT3-ITD and Wild-type NPM1: A Report from the EBMT Acute Leukemia Working Party
    Clin Cancer Res, 29 (21), 4441-4448
    DOI 10.1158/1078-0432.CCR-23-0954, PubMed 37603683
11. Cooper N, Ghanima W, Vianelli N, Valcárcel D, Yavaşoğlu İ, Melikyan A, Ruiz EY, Haenig J, Somenzi O, Lee J, Clark J, Zhang Y, Zaja F (2023)
    Sustained response off-treatment in eltrombopag-treated adult patients with ITP who are refractory or relapsed after first-line steroids: Primary, final, and ad-hoc analyses of the Phase II TAPER trial
    Am J Hematol, 99 (1), 57-67
    DOI 10.1002/ajh.27131, PubMed 38014779
12. Danielsen AS, Franconeri L, Page S, Myhre AE, Tornes RA, Kacelnik O, Bjørnholt JV (2023)
    Clinical outcomes of antimicrobial resistance in cancer patients: a systematic review of multivariable models
    BMC Infect Dis, 23 (1), 247
    DOI 10.1186/s12879-023-08182-3, PubMed 37072711
13. Dusingizimana T, Ramilan T, Weber JL, Iversen PO, Mugabowindekwe M, Ahishakiye J, Brough L (2023)
    Predictors for achieving adequate antenatal care visits during pregnancy: a cross-sectional study in rural Northwest Rwanda
    BMC Pregnancy Childbirth, 23 (1), 69
    DOI 10.1186/s12884-023-05384-0, PubMed 36703102
14. Ettingshausen CE, Hermans C, Holme PA, Cid AR, Khair K, Oldenburg J, Négrier C, Botha J, Lelli A, Windyga J (2023)
    Real-world data in patients with congenital hemophilia and inhibitors: final data from the FEIBA Global Outcome (FEIBA GO) study
    Ther Adv Hematol, 14, 20406207231184323
    DOI 10.1177/20406207231184323, PubMed 37529276
15. Fagerhol MK, Schultz NH, Mirlashari MR, Wiedmann MKH, Nissen-Meyer LSH, Søraas AVL, Hetland G (2023)
    DNase analysed by a novel competitive assay in patients with complications after ChAdOx1 nCoV-19 vaccination and in normal unvaccinated blood donors
    Scand J Immunol, 98 (1), e13274
    DOI 10.1111/sji.13274, PubMed 37676118
16. Federico L, Tvedt THA, Gainullin M, Osen JR, Chaban V, Lund KP, Tietze L, Tran TT, Lund-Johansen F, Kared H, Lind A, Vaage JT, Stratford R, Tennøe S, Malone B, Clancy T, Myhre AEL, Gedde-Dahl T, Munthe LA (2023)
    Robust spike-specific CD4⁺ and CD8⁺ T cell responses in SARS-CoV-2 vaccinated hematopoietic cell transplantation recipients: a prospective, cohort study
    Front Immunol, 14, 1210899
    DOI 10.3389/fimmu.2023.1210899, PubMed 37503339
17. Fløisand Y, Remberger M, Bigalke I, Josefsen D, Vålerhaugen H, Inderberg EM, Olaussen RW, Gjertsen BT, Goedkoop R, Geiger C, Prinz PU, Schnorfeil FM, Pinkernell K, Schendel DJ, Kvalheim G (2023)
    WT1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapy
    Leukemia, 37 (9), 1842-1849
    DOI 10.1038/s41375-023-01980-3, PubMed 37507426
18. Geelen IGP, Gullaksen SE, Ilander MM, Olssen-Strömberg U, Mustjoki S, Richter J, Blijlevens NMA, Smit WM, Gjertsen BT, Gedde-Dahl T, Markevärn B, Koppes MMA, Westerweel PE, Hjorth-Hansen H, Janssen JJWM (2023)
    Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects
    Ann Hematol, 102 (6), 1395-1408
    DOI 10.1007/s00277-023-05199-1, PubMed 37119314
19. Giannakopoulou E, Lehander M, Virding Culleton S, Yang W, Li Y, Karpanen T, Yoshizato T, Rustad EH, Nielsen MM, Bollineni RC, Tran TT, Delic-Sarac M, Gjerdingen TJ, Douvlataniotis K, Laos M, Ali M, Hillen A, Mazzi S, Chin DWL, Mehta A, Holm JS, Bentzen AK, Bill M, Griffioen M, Gedde-Dahl T et al. (2023)
    A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo
    Nat Cancer, 4 (10), 1474-1490
    DOI 10.1038/s43018-023-00642-8, PubMed 37783807
20. Gjærde LK, Ruutu T, Peczynski C, Boreland W, Kröger N, Blaise D, Schroeder T, Peffault de Latour R, Gedde-Dahl T, Kulagin A, Sengeløv H, Yakoub-Agha I, Finke J, Eder M, Basak G, Moiseev I, Schoemans H, Koenecke C, Penack O, Perić Z (2023)
    The impact of pre-transplantation diabetes and obesity on acute graft-versus-host disease, relapse and death after allogeneic hematopoietic cell transplantation: a study from the EBMT Transplant Complications Working Party
    Bone Marrow Transplant, 59 (2), 255-263
    DOI 10.1038/s41409-023-02154-6, PubMed 38062242
21. Gleditsch J, Jervan Ø, Klok F, Holst R, Hopp E, Tavoly M, Ghanima W (2023)
    Does the clot burden as assessed by the Mean Bilateral Proximal Extension of the Clot score reflect mortality and adverse outcome after pulmonary embolism?
    Acta Radiol Open, 12 (6), 20584601231187094
    DOI 10.1177/20584601231187094, PubMed 37426515
22. Gotlib J, Castells M, Elberink HO, Siebenhaar F, Hartmann K, Broesby-Olsen S, George TI, Panse J, Alvarez-Twose I, Radia DH, Tashi T, Bulai Livideanu C, Sabato V, Heaney M, Van Daele P, Cerquozzi S, Dybedal I, Reiter A, Pongdee T, Barete S, Ustun C, Schwartz L, Ward BR, Schafhausen P, Vadas P et al. (2023)
    Avapritinib versus Placebo in Indolent Systemic Mastocytosis
    NEJM Evid, 2 (6), EVIDoa2200339
    DOI 10.1056/EVIDoa2200339, PubMed 38320129
23. Groen K, Schjesvold FH, van der Holt B, Levin MD, Seefat MR, Hansson M, Leys MBL, Regelink JC, Waage A, Szatkowski D, Axelsson P, Hieu Do T, Svirskaite A, van der Spek E, Haukas E, Knut-Bojanowska D, Ypma PF, Blimark CH, Mellqvist UH, van de Donk NWCJ, Sonneveld P, Klostergaard A, Vangsted AJ, Abildgaard N, Zweegman S (2023)
    Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13
    Hemasphere, 7 (9), e940
    DOI 10.1097/HS9.0000000000000940, PubMed 37663673
24. Gudmundstuen AM, Efficace F, Tjønnfjord GE, Skaarud KJ, Cottone F, Hjermstad MJ, Iversen PO (2023)
    The prognostic value of patient-reported outcomes in allogeneic hematopoietic stem cell transplantation: exploratory analysis of a randomized nutrition intervention trial
    Ann Hematol, 102 (4), 927-935
    DOI 10.1007/s00277-023-05149-x, PubMed 36864210
25. Gundesen MT, Asmussen JT, Schjesvold F, Vangsted AJ, Helleberg C, Haukås E, Silkjær T, Teodorescu EM, Jensen BA, Slørdahl TS, Nahi H, Waage A, Abildgaard N, Lund T, Nordic Myeloma Study Group (2023)
    Potential value of pre-planned imaging of bone disease in multiple myeloma
    Blood Cancer J, 13 (1), 105
    DOI 10.1038/s41408-023-00880-0, PubMed 37419876
26. Harrison SP, Siller R, Tanaka Y, Chollet ME, de la Morena-Barrio ME, Xiang Y, Patterson B, Andersen E, Bravo-Pérez C, Kempf H, Åsrud KS, Lunov O, Dejneka A, Mowinckel MC, Stavik B, Sandset PM, Melum E, Baumgarten S, Bonanini F, Kurek D, Mathapati S, Almaas R, Sharma K, Wilson SR, Skottvoll FS et al. (2023)
    Scalable production of tissue-like vascularized liver organoids from human PSCs
    Exp Mol Med, 55 (9), 2005-2024
    DOI 10.1038/s12276-023-01074-1, PubMed 37653039
27. Hasanaliyeva G, Sufar EK, Wang J, Rempelos L, Volakakis N, Iversen PO, Leifert C (2023)
    Effects of Agricultural Intensification on Mediterranean Diets: A Narrative Review
    Foods, 12 (20)
    DOI 10.3390/foods12203779, PubMed 37893672
28. Hermans C, Astermark J, Carvalho M, Dolan G, d'Oiron R, Fontana P, Holme PA, Kenet G, Klamroth R, Mancuso ME, Marquardt N, Nunez R, Katsarou O, Pabinger-Fasching I, Quintavalle G, Rodgers R, van der Valk P, Windyga J, Jimenez Yuste V, Preložnik Zupan I (2023)
    Prevalence of COVID-19 related hospitalizations and mortality in adults aged ≥40 years with haemophilia: A survey from Europe
    Haemophilia, 29 (3), 913-916
    DOI 10.1111/hae.14761, PubMed 36802089
29. Hermansen JU, Yin Y, Urban A, Myklebust CV, Karlsen L, Melvold K, Tveita AA, Taskén K, Munthe LA, Tjønnfjord GE, Skånland SS (2023)
    A tumor microenvironment model of chronic lymphocytic leukemia enables drug sensitivity testing to guide precision medicine
    Cell Death Discov, 9 (1), 125
    DOI 10.1038/s41420-023-01426-w, PubMed 37055391
30. Hernández-Boluda JC, Eikema DJ, Koster L, Kröger N, Robin M, de Witte M, Finke J, Finazzi MC, Broers A, Raida L, Schaap N, Chiusolo P, Verbeek M, Hazenberg CLE, Halaburda K, Kulagin A, Labussière-Wallet H, Gedde-Dahl T, Rabitsch W, Raj K, Drozd-Sokolowska J, Battipaglia G, Polverelli N, Czerw T, Yakoub-Agha I et al. (2023)
    Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT
    Bone Marrow Transplant, 58 (12), 1357-1367
    DOI 10.1038/s41409-023-02094-1, PubMed 37679647
31. Hillarp A, Holme PA, Wåland EP, Le MS, Henriksson CE, Tjønnfjord GE, Måseide RJ (2023)
    Report on 4 cases with decreased recovery due to neutralizing antibodies specific for PEGylated recombinant factor VIII
    J Thromb Haemost, 21 (10), 2771-2775
    DOI 10.1016/j.jtha.2023.07.019, PubMed 37543216
32. Iversen PO, Fogelholm M (2023)
    Fluid and water balance: a scoping review for the Nordic Nutrition Recommendations 2023
    Food Nutr Res, 67
    DOI 10.29219/fnr.v67.9975, PubMed 38084150
33. Jervan Ø, Dhayyat A, Gleditsch J, Haukeland-Parker S, Tavoly M, Klok FA, Rashid D, Stavem K, Ghanima W, Steine K (2023)
    Demographic, clinical, and echocardiographic factors associated with residual perfusion defects beyond six months after pulmonary embolism
    Thromb Res, 229, 7-14
    DOI 10.1016/j.thromres.2023.06.004, PubMed 37356172
34. Jervan Ø, Haukeland-Parker S, Gleditsch J, Tavoly M, Klok FA, Steine K, Johannessen HH, Spruit MA, Atar D, Holst R, Astrup Dahm AE, Sirnes PA, Stavem K, Ghanima W (2023)
    The Effects of Exercise Training in Patients With Persistent Dyspnea Following Pulmonary Embolism: A Randomized Controlled Trial
    Chest, 164 (4), 981-991
    DOI 10.1016/j.chest.2023.04.042, PubMed 37149257
35. Jørgensen CT, Brækkan SK, Førsund E, Pettersen HH, Tjønnfjord E, Ghanima W, Tavoly M (2023)
    Incidence of venous thromboembolism, recurrence, and bleeding after isolated superficial vein thrombosis: findings from the Venous Thrombosis Registry in Østfold Hospital
    J Thromb Haemost, 22 (2), 526-533
    DOI 10.1016/j.jtha.2023.10.017, PubMed 37913911
36. Jørgensen CT, Tavoly M, Førsund E, Pettersen HH, Tjønnfjord E, Ghanima W, Brækkan SK (2023)
    Incidence of bleeding and recurrence in isolated distal deep vein thrombosis: findings from the Venous Thrombosis Registry in Østfold Hospital
    J Thromb Haemost, 21 (10), 2824-2832
    DOI 10.1016/j.jtha.2023.06.028, PubMed 37394122
37. Jørgensen OJ, Steineger JE, Hillarp A, Pareli Wåland E, Holme PA, Heimdal K, Dheyauldeen S (2023)
    Elevated FVIII levels in hereditary hemorrhagic telangiectasia: Implications for clinical management
    Laryngoscope Investig Otolaryngol, 9 (1), e1196
    DOI 10.1002/lio2.1196, PubMed 38362186
38. Kihlberg K, Baghaei F, Bruzelius M, Funding E, Andre Holme P, Lassila R, Nummi V, Ranta S, Gretenkort Andersson N, Berntorp E, Astermark J (2023)
    No difference in quality of life between persons with severe haemophilia A and B
    Haemophilia, 29 (4), 987-996
    DOI 10.1111/hae.14759, PubMed 36791275
39. Kisali EP, Iversen PO, Makani J, Sickle Cell Programme, MUHAS (2023)
    Low vitamin B₁₂ blood levels in sickle cell disease: Data from a large cohort study in Tanzania
    Br J Haematol, 204 (3), 1047-1053
    DOI 10.1111/bjh.19265, PubMed 38087805
40. Kreyberg I, Schrumpf E, Fredrik von Krogh C, Lilleng R, Tjønnfjord GE (2023)
    Successful treatment of subcorneal pustular dermatosis targeting an underlying monoclonal IgA gammopathy
    JAAD Case Rep, 41, 33-36
    DOI 10.1016/j.jdcr.2023.08.036, PubMed 37842157
41. Kristoffersen I, Holte K, Antonsen LP, Ho APT, Kvenshagen LN, Løgavlen VV, Murugaiah P, Tjønnfjord E, Værnesbranden MR (2023)
    A pregnant woman in her thirties with abdominal pain, seizures and haemorrhagic shock
    Tidsskr Nor Laegeforen, 143 (5)
    DOI 10.4045/tidsskr.22.0282, PubMed 36987892
42. Kverneland M, Nakken KO, Hofoss D, Skogan AH, Iversen PO, Selmer KK, Lossius MI (2023)
    Health-related quality of life in adults with drug-resistant focal epilepsy treated with modified Atkins diet in a randomized clinical trial
    Epilepsia, 64 (5), e69-e74
    DOI 10.1111/epi.17585, PubMed 36923995
43. Köhn-Luque A, Myklebust EM, Tadele DS, Giliberto M, Schmiester L, Noory J, Harivel E, Arsenteva P, Mumenthaler SM, Schjesvold F, Taskén K, Enserink JM, Leder K, Frigessi A, Foo J (2023)
    Phenotypic deconvolution in heterogeneous cancer cell populations using drug-screening data
    Cell Rep Methods, 3 (3), 100417
    DOI 10.1016/j.crmeth.2023.100417, PubMed 37056380
44. Larsen TL, Svalastoga M, Brekke J, Enden T, Frøen H, Garresori H, Jacobsen EM, Paulsen PQ, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA (2023)
    Arterial events in cancer patients treated with apixaban for venous thrombosis
    Thromb Res, 228, 128-133
    DOI 10.1016/j.thromres.2023.05.017, PubMed 37327527
45. Ludwig H, Terpos E, van de Donk N, Mateos MV, Moreau P, Dimopoulos MA, Delforge M, Rodriguez-Otero P, San-Miguel J, Yong K, Gay F, Einsele H, Mina R, Caers J, Driessen C, Musto P, Zweegman S, Engelhardt M, Cook G, Weisel K, Broijl A, Beksac M, Bila J, Schjesvold F, Cavo M et al. (2023)
    Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network
    Lancet Oncol, 24 (6), e255-e269
    DOI 10.1016/S1470-2045(23)00159-6, PubMed 37269857
46. Matlary RED, Grydeland M, Glosli H, Rueegg CS, Holme PA (2023)
    Physical activity in Norwegian teenagers and young adults with haemophilia A compared to general population peers
    Haemophilia, 29 (2), 658-667
    DOI 10.1111/hae.14752, PubMed 36723510
47. Matlary RED, Grydeland M, Glosli H, Rueegg CS, Holme PA (2023)
    Factors associated with physical activity in young people with haemophilia A on prophylaxis
    Haemophilia, 29 (3), 900-909
    DOI 10.1111/hae.14776, PubMed 36913380
48. Meshkovska B, Gebremariam MK, Atukunda P, Iversen PO, Wandel M, Lien N (2023)
    Barriers and facilitators to implementation of nutrition-related actions in school settings in low- and middle-income countries (LMICs): a qualitative systematic review using the Consolidated Framework for Implementation Research (CFIR)
    Implement Sci Commun, 4 (1), 73
    DOI 10.1186/s43058-023-00454-y, PubMed 37370179
49. Molteberg E, Thorsby PM, Kverneland M, Iversen PO, Selmer KK, Hofoss D, Nakken KO, Taubøll E (2023)
    Stress biomarkers in adult patients with drug-resistant epilepsy on a modified Atkins diet: A prospective study
    Epilepsia Open, 8 (4), 1331-1339
    DOI 10.1002/epi4.12808, PubMed 37574592
50. Moore KLF, Turesson I, Genell A, Klausen TW, Knut-Bojanowska D, Redder L, Sverrisdottir I, Thorsen J, Vangsted AJ, Blimark CH (2023)
    Improved survival in myeloma patients-a nationwide registry study of 4,647 patients ≥75 years treated in Denmark and Sweden
    Haematologica, 108 (6), 1640-1651
    DOI 10.3324/haematol.2021.280424, PubMed 36300775
51. Myklebust-Hansen HJ, Hasvik E, Solyga VM, Ghanima W (2023)
    The feasibility of self-performing measurements of peripheral oxygen saturation and respiratory exercises in home-isolated COVID-19 patients-a single-arm prospective trial
    Pilot Feasibility Stud, 9 (1), 195
    DOI 10.1186/s40814-023-01415-x, PubMed 38042811
52. Måseide RJ, Berntorp E, Astermark J, Olsson A, Bruzelius M, Frisk T, Nummi V, Lassila R, Tjønnfjord GE, Holme PA (2023)
    Health-related quality of life and physical activity in Nordic patients with moderate haemophilia A and B (the MoHem study)
    Haemophilia, 30 (1), 98-105
    DOI 10.1111/hae.14899, PubMed 37983883
53. Nagler A, Labopin M, Kröger N, Schroeder T, Gedde-Dahl T, Eder M, Franke GN, Blau IW, Salmenniemi U, Socie G, Schetelig J, Stelljes M, Ciceri F, Mohty M (2023)
    The role of anti-thymocyte globulin in allogeneic stem cell transplantation (HSCT) from HLA-matched unrelated donors (MUD) for secondary AML in remission: a study from the ALWP /EBMT
    Bone Marrow Transplant, 58 (12), 1339-1347
    DOI 10.1038/s41409-023-02095-0, PubMed 37660157
54. Nagler A, Labopin M, Mielke S, Passweg J, Blaise D, Gedde-Dahl T, Cornelissen JJ, Salmenniemi U, Yakoub-Agha I, Reményi P, Socié G, van Gorkom G, Labussière-Wallet H, Huang XJ, Rubio MT, Byrne J, Craddock C, Griškevičius L, Ciceri F, Mohty M (2023)
    Matched related versus unrelated versus haploidentical donors for allogeneic transplantation in AML patients achieving first complete remission after two induction courses: a study from the ALWP/EBMT
    Bone Marrow Transplant, 58 (7), 791-800
    DOI 10.1038/s41409-023-01980-y, PubMed 37045942
55. Nahalomo A, Iversen PO, Andreassen BA, Kaaya A, Rukooko AB, Rukundo PM (2023)
    Food insecurity, dietary diversity and the right to adequate food among households in landslide-prone communities in Eastern Uganda: A cohort study
    PLoS One, 18 (4), e0283078
    DOI 10.1371/journal.pone.0283078, PubMed 37053147
56. Nezvalova-Henriksen K, Langebrake C, Bauters T, Moreno-Martinez ME, Ahnfelt E, Ekelund H, Domingos V, Pires V, Bonnin A, Bojanić I, Cabrerizo Y, Terwel S, Tam A (2023)
    Implementation and operational management of marketed chimeric antigen receptor T cell (CAR-T Cell) therapy-a guidance by the GoCART Coalition Pharmacist Working Group
    Bone Marrow Transplant, 58 (10), 1069-1074
    DOI 10.1038/s41409-023-02072-7, PubMed 37528237
57. Nyquist OE, Dalgaard J, Spetalen S, Torkildsen S, Frøen H, Galteland E, Klungsøyr O, Bergrem A, Vo C, Sørbø H, Eiken B, Lerdal H, Solvang AK, Jensvoll H, Pandzic T, Baliakas P, Dybedal I (2023)
    Pathogenic DDX41 variants, possible response predictors to low-dose melphalan in hypo- and normocellular MDS and AML
    Br J Haematol, 204 (2), 724-729
    DOI 10.1111/bjh.19226, PubMed 38016923
58. Nørgaard JN, Abildgaard N, Lysén A, Tsykunova G, Vangsted AJ, João C, Remen N, Nielsen LK, Osnes L, Stokke C, Connelly JP, Revheim MR, Nordic Myeloma Study Group (NMSG), Schjesvold F (2023)
    Intensifying treatment in PET-positive multiple myeloma patients after upfront autologous stem cell transplantation
    Leukemia, 37 (10), 2107-2114
    DOI 10.1038/s41375-023-01998-7, PubMed 37568010
59. Oriol A, Dimopoulos M, Schjesvold F, Beksac M, Facon T, Dhanasiri S, Guo S, Mu Y, Hong K, Gentili C, Galli M, Yagci M, Larocca A, Richardson P, Weisel K (2023)
    Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma: A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose Adjustment
    Clin Lymphoma Myeloma Leuk, 24 (3), 165-176.e4
    DOI 10.1016/j.clml.2023.10.009, PubMed 38072743
60. Panagopoulos I, Andersen K, Wik HS, Tandsæther MR, Micci F, Heim S (2023)
    Acute Undifferentiated Leukemia With a Balanced t(5;10)(q35;p12) Resulting in Fusion of HNRNPH1 With MLLT10
    Cancer Genomics Proteomics, 20 (4), 354-362
    DOI 10.21873/cgp.20387, PubMed 37400142
61. Pedersen S, Kverneland M, Rudi K, Gervin K, Landmark CJ, Iversen PO, Selmer KK (2023)
    Decreased serum concentrations of antiseizure medications in children with drug resistant epilepsy following treatment with ketogenic diet
    Epilepsia Open, 8 (3), 858-866
    DOI 10.1002/epi4.12746, PubMed 37057954
62. Plesner T, Harrison SJ, Quach H, Lee C, Bryant A, Vangsted A, Estell J, Delforge M, Offner F, Twomey P, Choeurng V, Li J, Hendricks R, Ruppert SM, Sumiyoshi T, Miller K, Cho E, Schjesvold F (2023)
    Phase I Study of Safety and Pharmacokinetics of RO7297089, an Anti-BCMA/CD16a Bispecific Antibody, in Patients with Relapsed, Refractory Multiple Myeloma
    Clin Hematol Int, 5 (1), 43-51
    DOI 10.1007/s44228-022-00023-5, PubMed 36656461
63. Poiré X, Labopin M, Polge E, Ganser A, Socié G, Gedde-Dahl T, Forcade E, Finke J, Chalandon Y, Bulabois CE, Yakoub-Agha I, Aljurf M, Kröger N, Blau IW, Nagler A, Esteve J, Mohty M (2023)
    Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with hyperdiploid complex karyotype
    Bone Marrow Transplant, 59 (2), 264-269
    DOI 10.1038/s41409-023-02167-1, PubMed 38092959
64. Pradier M, Rodger MA, Ghanima W, Kovacs MJ, Shivakumar S, Kahn SR, Sandset PM, Kearon C, Mallick R, Delluc A (2023)
    Performance and Head-to-Head Comparison of Three Clinical Models to Predict Occurrence of Postthrombotic Syndrome: A Validation Study
    Thromb Haemost, 123 (7), 692-699
    DOI 10.1055/a-2039-3388, PubMed 36809776
65. Reding MT, Pabinger I, Holme PA, Maas Enriquez M, Mancuso ME, Lalezari S, Miesbach W, Di Minno G, Klamroth R, Hermans C (2023)
    Efficacy and safety of damoctocog alfa pegol prophylaxis in patients ⩾40 years with severe haemophilia A and comorbidities: post hoc analysis from the PROTECT VIII study
    Ther Adv Hematol, 14, 20406207231166779
    DOI 10.1177/20406207231166779, PubMed 37113811
66. Rempelos L, Wang J, Sufar EK, Almuayrifi MSB, Knutt D, Leifert H, Leifert A, Wilkinson A, Shotton P, Hasanaliyeva G, Bilsborrow P, Wilcockson S, Volakakis N, Markellou E, Zhao B, Jones S, Iversen PO, Leifert C (2023)
    Breeding Bread-Making Wheat Varieties for Organic Farming Systems: The Need to Target Productivity, Robustness, Resource Use Efficiency and Grain Quality Traits
    Foods, 12 (6)
    DOI 10.3390/foods12061209, PubMed 36981136
67. Rinde FB, Jørgensen CT, Pettersen HH, Hansen JB, Ghanima W, Braekkan SK (2023)
    Low D-dimer levels at diagnosis of venous thromboembolism are associated with reduced risk of recurrence: data from the TROLL registry
    J Thromb Haemost, 21 (7), 1861-1868
    DOI 10.1016/j.jtha.2023.03.026, PubMed 37004791
68. Robin C, Cordonnier C, Tridello G, Knelange N, Xhaard A, Chantepie S, Tanguy-Schmidt A, Schouten HC, Yeshurun M, Rocha V, Srour M, Kröger N, Ledoux MP, Dalgaard J, Thiebaut A, Giardino S, Calore E, Zuckerman T, Groll AH, Raida L, Avcin S, Vicent MG, Kaare A, Drozd-Sokolowska J, Turlure P et al. (2023)
    Pneumocystis Pneumonia After Allogeneic Hematopoietic Cell Transplantation: A Case-Control Study on Epidemiology and Risk Factors on Behalf of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation
    Transplant Cell Ther, 30 (2), 235.e1-235.e10
    DOI 10.1016/j.jtct.2023.11.017, PubMed 38007092
69. Roman G, Stavik B, Lauritzen KH, Sandset PM, Harrison SP, Sullivan GJ, Chollet ME (2023)
    "iPSC-derived liver organoids and inherited bleeding disorders: Potential and future perspectives"
    Front Physiol, 14, 1094249
    DOI 10.3389/fphys.2023.1094249, PubMed 36711019
70. Ruggeri A, De Wreede LC, Müller CR, Crivello P, Bonneville EF, Petersdorf EW, Socié G, Dubois V, Niittyvuopio R, Peräsaari J, Yakoub-Agha I, Cornelissen JJ, Wieten L, Gedde-Dahl T, Forcade E, Crawley CR, Marsh SGE, Gandemer V, Tholouli E, Bulabois CE, Huynh A, Choi G, Deconinck E, Itäla-Remes M, Lenhoff S et al. (2023)
    Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation
    Haematologica, 108 (2), 645-652
    DOI 10.3324/haematol.2021.280055, PubMed 35546480
71. Rørvik SD, Abrahamsen IW, Myhre AE, Vo CD, Ødegaard EM, Bruserud Ø, Gedde-Dahl T, Tvedt THA (2023)
    [Chronic graft-versus-host disease]
    Tidsskr Nor Laegeforen, 143 (4)
    DOI 10.4045/tidsskr.22.0525, PubMed 36919292
72. Raab MS, Cohen YC, Schjesvold F, Aardalen K, Oka A, Spencer A, Wermke M, Souza AD, Kaufman JL, Cafro AM, Ocio EM, Doki N, Henson K, Trabucco G, Carrion A, Bender FC, Juif PE, Fessehatsion A, Fan L, Stonehouse JP, Blankenship JW, Granda B, De Vita S, Lu H (2023)
    Preclinical discovery and initial clinical data of WVT078, a BCMA × CD3 bispecific antibody
    Leukemia, 37 (6), 1349-1360
    DOI 10.1038/s41375-023-01883-3, PubMed 37024520
73. Raab MS, Zamagni E, Manier S, Rodriguez-Otero P, Schjesvold F, Broijl A (2023)
    Difficult-to-treat patients with relapsed/refractory multiple myeloma: A review of clinical trial results
    EJHaem, 4 (4), 1117-1131
    DOI 10.1002/jha2.743, PubMed 38024633
74. Sanz J, Labopin M, Pabst T, Versluis J, Van Gorkom G, Meijer E, Gedde-Dahl T, Montoro J, Arcese W, Pérez-Simón JA, Schaap N, Maertens J, Vrhovac R, Lanza F, Gorin NC, Mohty M, Ciceri F (2023)
    Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT
    Bone Marrow Transplant, 58 (11), 1197-1202
    DOI 10.1038/s41409-023-02075-4, PubMed 37553468
75. Schjesvold FH, Ludwig H, Mateos MV, Larocca A, Abdulhaq H, Norin S, Thuresson M, Bakker NA, Richardson PG, Sonneveld P (2023)
    Melflufen in relapsed/refractory multiple myeloma refractory to prior alkylators: A subgroup analysis from the OCEAN study
    Eur J Haematol, 112 (3), 402-411
    DOI 10.1111/ejh.14127, PubMed 37968873
76. Schultz NH, Bechensteen AG, Tjønnfjord EB, Akkök ÇA, Berg MH (2023)
    New interest group for red blood cell disorders
    Tidsskr Nor Laegeforen, 143 (3)
    DOI 10.4045/tidsskr.22.0731, PubMed 36811425
77. Shapiro AD, Nakar C, Parker JM, Thibaudeau K, Crea R, Sandset PM (2023)
    Plasminogen, human-tvmh for the treatment of children and adults with plasminogen deficiency type 1
    Haemophilia, 29 (6), 1556-1564
    DOI 10.1111/hae.14849, PubMed 37674358
78. Sonneveld P, Dimopoulos MA, Boccadoro M, Quach H, Ho PJ, Beksac M, Hulin C, Antonioli E, Leleu X, Mangiacavalli S, Perrot A, Cavo M, Belotti A, Broijl A, Gay F, Mina R, Nijhof IS, van de Donk NWCJ, Katodritou E, Schjesvold F, Sureda Balari A, Rosiñol L, Delforge M, Roeloffzen W, Silzle T et al. (2023)
    Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
    N Engl J Med, 390 (4), 301-313
    DOI 10.1056/NEJMoa2312054, PubMed 38084760
79. Sonneveld P, Richardson PG, Ludwig H, Dimopoulos MA, Schjesvold FH, Hájek R, Abdulhaq H, Thuresson M, Norin S, Bakker NA, Mateos MV (2023)
    Benefit Versus Risk Assessment of Melflufen and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Analyses From Longer Follow-up of the OCEAN and HORIZON Studies
    Clin Lymphoma Myeloma Leuk, 23 (9), 687-696
    DOI 10.1016/j.clml.2023.05.004, PubMed 37355418
80. Spyridonidis A, Labopin M, Gedde-Dahl T, Ganser A, Stelljes M, Craddock C, Wagner-Drouet EM, Versluis J, Schroeder T, Blau IW, Wulf GG, Dreger P, Olesen G, Sengeloev H, Kröger N, Potter V, Forcade E, Passweg J, de Latour RP, Maertens J, Wilson KMO, Bourhis JH, Finke J, Brissot E, Bazarbachi A et al. (2023)
    Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation
    Bone Marrow Transplant, 59 (2), 217-223
    DOI 10.1038/s41409-023-02139-5, PubMed 37978322
81. Terpos E, Musto P, Engelhardt M, Delforge M, Cook G, Gay F, van de Donk NWCJ, Ntanasis-Stathopoulos I, Vangsted AJ, Driessen C, Schjesvold F, Cerchione C, Zweegman S, Hajek R, Moreau P, Einsele H, San-Miguel J, Boccadoro M, Dimopoulos MA, Sonneveld P, Ludwig H (2023)
    Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)
    Leukemia, 37 (6), 1175-1185
    DOI 10.1038/s41375-023-01920-1, PubMed 37142661
82. Tholin B, Ghanima W, Selle ML, Stavem K (2023)
    Incidence and determinants of venous thromboembolism over 90 days in hospitalized and nonhospitalized patients with COVID-19
    J Intern Med, 294 (6), 721-729
    DOI 10.1111/joim.13706, PubMed 37518983
83. Tislevoll BS, Hellesøy M, Fagerholt OHE, Gullaksen SE, Srivastava A, Birkeland E, Kleftogiannis D, Ayuda-Durán P, Piechaczyk L, Tadele DS, Skavland J, Baliakas P, Hovland R, Andresen V, Seternes OM, Tvedt THA, Aghaeepour N, Gavasso S, Porkka K, Jonassen I, Fløisand Y, Enserink J, Blaser N, Gjertsen BT (2023)
    Early response evaluation by single cell signaling profiling in acute myeloid leukemia
    Nat Commun, 14 (1), 115
    DOI 10.1038/s41467-022-35624-4, PubMed 36611026
84. Tislevoll BS, Hellesøy M, Fagerholt OHE, Gullaksen SE, Srivastava A, Birkeland E, Kleftogiannis D, Ayuda-Durán P, Piechaczyk L, Tadele DS, Skavland J, Baliakas P, Hovland R, Andresen V, Seternes OM, Tvedt THA, Aghaeepour N, Gavasso S, Porkka K, Jonassen I, Fløisand Y, Enserink J, Blaser N, Gjertsen BT (2023)
    Author Correction: Early response evaluation by single cell signaling profiling in acute myeloid leukemia
    Nat Commun, 14 (1), 1767
    DOI 10.1038/s41467-023-37488-8, PubMed 36997540
85. Tjønnfjord SKV, Ali MM, Tjønnfjord GE (2023)
    Chronic neutropenia in adults
    Tidsskr Nor Laegeforen, 143 (9)
    DOI 10.4045/tidsskr.22.0491, PubMed 37341406
86. Troensegaard H, Khoury J, Westerberg AC, Tonstad S, Roeters van Lennep J, Veierød MB, Iversen PO, Holven KB, Retterstøl K (2023)
    Protocol for a 20-year follow-up after a randomized controlled trial of a Mediterranean diet in pregnancy: maternal and offspring risk factors for cardiovascular disease
    Front Pediatr, 11, 1256815
    DOI 10.3389/fped.2023.1256815, PubMed 37920793
87. Trøseid M, Arribas JR, Assoumou L, Holten AR, Poissy J, Terzić V, Mazzaferri F, Baño JR, Eustace J, Hites M, Joannidis M, Paiva JA, Reuter J, Püntmann I, Patrick-Brown TDJH, Westerheim E, Nezvalova-Henriksen K, Beniguel L, Dahl TB, Bouscambert M, Halanova M, Péterfi Z, Tsiodras S, Rezek M, Briel M et al. (2023)
    Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
    Crit Care, 27 (1), 9
    DOI 10.1186/s13054-022-04205-8, PubMed 36627655
88. Tsykunova G, Kristensen E, Stray-Pedersen A, Bruserud Ø, Sørensen IW, Bruserud Ø, Tvedt THA (2023)
    Adult presentation of ornithine transcarbamylase deficiency: a possible cause of hyperammonemia after high-dose chemotherapy and stem cell transplantation
    Hematology, 28 (1), 2265187
    DOI 10.1080/16078454.2023.2265187, PubMed 38078487
89. Ueland T, Michelsen AE, Tveita AA, Kåsine T, Dahl TB, Finbråten AK, Holten AR, Skjønsberg OH, Mathiessen A, Henriksen KN, Trøseid M, Aaløkken TM, Halvorsen B, Dyrhol-Riise AM, Barratt-Due A, Aukrust P (2023)
    Coagulopathy and adverse outcomes in hospitalized patients with COVID-19: results from the NOR-Solidarity trial
    Res Pract Thromb Haemost, 8 (1), 102289
    DOI 10.1016/j.rpth.2023.102289, PubMed 38292350
90. van de Donk NWCJ, Minnema MC, van der Holt B, Schjesvold F, Wu KL, Broijl A, Roeloffzen WWH, Gadisseur A, Pietrantuono G, Pour L, van der Velden VHJ, Lund T, Offidani M, Grasso M, Giaccone L, Razawy W, Tacchetti P, Mancuso K, Silkjaer T, Caers J, Zweegman S, Hájek R, Benjamin R, Vangsted AJ, Boccadoro M et al. (2023)
    Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study
    Lancet Oncol, 24 (10), 1119-1133
    DOI 10.1016/S1470-2045(23)00405-9, PubMed 37717583
91. Vinnes EW, Lillemoen PKS, Klingenberg O, Fjeld B, Iversen PO, Brodwall KM, Bechensteen AG (2023)
    [Sickle cell disease – clinical manifestations and diagnostics]
    Tidsskr Nor Laegeforen, 143 (3)
    DOI 10.4045/tidsskr.22.0353, PubMed 36811424
92. Vo CD, Myhre AE, Abrahamsen IW, Remberger M, Mattsson J, Fløisand Y, Grønvold BCL, Tjønnfjord GE, Tvedt THA, Gedde-Dahl T (2023)
    Allogeneic stem cell transplantation in adults 2015-21
    Tidsskr Nor Laegeforen, 143 (4)
    DOI 10.4045/tidsskr.22.0521, PubMed 36919291
93. Warlo EMK, Kalstad AA, Myhre PL, Solheim S, Arnesen H, Tveit A, Holme PA, Seljeflot I, Bratseth V (2023)
    von Willebrand factor, ADAMTS-13, and thrombospondin 1 in relation to clinical outcomes in elderly patients with a recent myocardial infarction
    Res Pract Thromb Haemost, 7 (4), 100164
    DOI 10.1016/j.rpth.2023.100164, PubMed 37255854
94. Westhrin M, Blazevski J, Textor A, Abdollahi P, Gopalakrishnan RP, Ngo LT, Hofgaard PO, Heinzelbecker J, Bobic S, Fossum E, Spång HCL, Braathen R, Bogen B (2023)
    Id-neoantigen vaccine induces therapeutic CD8⁺ T cells against multiple myeloma: H chain-loss escapees cause FLC MM
    J Immunother Cancer, 11 (8)
    DOI 10.1136/jitc-2023-006944, PubMed 37607769
95. Ågnes C, Schwartz T, Quist-Paulsen E, Bhatti R, Njaastad AM, Fuglestved J, Wibetoe G (2023)
    Drug-induced aseptic meningitis
    Tidsskr Nor Laegeforen, 143 (1)
    DOI 10.4045/tidsskr.22.0286, PubMed 36655954